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Abstract 
 
The immunosensor combined with surface-enhanced Raman scattering (SERS) has been recognized as a 
powerful analytical tool for trace protein detection. The use of SERS as a readout method has attracted much 
interest because of its advantages, such as high sensitive, nondestructive, no photobleaching and fast detection. 
Highly sensitive immunosensor can be realized by combining specific recognition of antigen-antibody 
interactions and high signal enhancement of the SERS effect. Since all proteins are assembled from the similar 
basic constituents, it is difficult to distinguish the difference of proteins from their Raman spectra. Therefore, 
the extrinsic SERS immunoassay has been mostly employed for identification the target analyte from other 
proteins by using SERS probe (antibody-conjugated metal nanoparticles (MNPs) labeled with Raman reporter 
molecule) as Raman signal generator. The strong and distinctive Raman spectra of Raman reporter molecule 
are used to detect the selective antigen-antibody recognition. In general, the extrinsic SERS immunosensor 
consists of the antigen, antibody, SERS probe, and solid substrate. Typically, SERS immunoassay was 
performed on flat substrates such as polydimethylsiloxane (PDMS) well plate, glass or gold (Au) substrate. 
No significant electric field enhancement can be expected from the flat substrate. Therefore, in these systems, 
the enhancement of Raman signal solely comes from the localized surface plasmon resonance (LSPR) of SERS 
probes. By changing the flat substrate with a nanostructured metallic substrate (SERS substrate), the extra 
enhancement can be expected through the strong plasmon coupling between the SERS substrate and probes, 
leading to sensitivity enhancement. In this study, we aimed to improve the sensitivity of SERS immunosensor 
by using SERS substrates instead of flat substrates. To realize highly sensitive SERS immunosensors, the 
following experiments were conducted.  
 In this work, wavelength-tunable SERS substrates with a high binding affinity with the biomolecule 
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and SERS probes were fabricated. The SERS probes are antibodies-capped Au nanoparticles (AuNPs) labeled 
with Raman reporter molecules, which are the thiolated molecules that can chemisorb on MNPs and produce 
strong and unique Raman spectra. The SERS substrates are two-dimensional (2D) arrays of gold core@silver 
shell (Au@Ag) NPs deposited on indium-tin-oxide (ITO) substrates, which were previously reported as high 
SERS-active substrates by our group. The substrates were prepared by our original hybrid method, which is a 
bottom-up deposition method based on self-assembly of alkanethiolate-capped MNPs. The LSPR of the 2D 
arrays was tuned to a He-Ne laser line of 633 nm by designing the particle structure of Au@Ag NPs: the 
particle size and the molar ratio of Au/Ag. In the 2D arrays fabrication process, the Au@Ag NPs were capped 
with a mixed alkanethiolate self-assembled monolayer by treating with a mixture of dodecanethiol and 
octadecanethiol (6:1 molar ratio). Thus, the as-prepared 2D arrays of Au@Ag core-shell NPs are hydrophobic, 
which is not suitable for interacting with biomolecules. Thus, the 2D arrays of Au@Ag core-shell NPs must 
be hydrophilized before utilizing it as a SERS substrate of immunosensors using an aqueous solution. The 
hydrophilization was successfully performed by replacing hydrophobic molecules of mixed alkanethiols with 
a hydrophilic molecule of 16-mercaptohexadecanoic acid (MHDA). By performing immunoassay on 
hydrophilized SERS substrates, the sensitivity improvement of SERS immunosensor was achieved. Two 
immunoassay formats were used: direct-type and sandwich-type immunoassays. In the direct-type SERS 
immunoassay, the target antigen is directly immobilized on the substrate, and the amount of them is quantified 
by detecting the signal from SERS probes. In the sandwich-type immunoassay, the antigen is sandwiched 
between the capture antibody immobilized on the SERS-active substrate and the detection antibody 
immobilized on the SERS probes. The amount of antigen is quantified by measuring the signal of the SERS 
probes. This format enables high sensitive and specific detection. 
The principle study of the sensitivity improvement by employing the SERS substrates was firstly 
performed using a direct immunoassay format. The nucleoprotein of influenza A virus, which is one of the 
most conserved and abundant structural proteins on the virion, was used as a target. Highly sensitive 
immunosensors were realized by combining specific recognition of antibody-antigen interaction and high 
signal enhancement of SERS effect. SERS probes were fabricated by decorating PEGylated, 4, 4’-
thiobisbenzenethiol (TBBT)-labeled 25 nm-size AuNPs with Influenza A antibodies. The SERS signal of 
TBBT at 1565 cm-1 was utilized to detect the selective nucleoprotein-antibody recognition. The stronger 
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Raman signal was observed for the SERS substrate than for the Au film substrate under the same concentration 
of the target. The sensitivity was enhanced 4 times by using the SERS substrates instead of a flat Au film. 
The limit of detection (LOD) of the immunoassay using the SERS substrate was 8 ng/mL, while that using the 
Au film substrate was 59 ng/mL. These results indicate that using a well-tuned Au@Ag 2D array as a SERS 
substrate is an effective way for improving the sensitivity of SERS-based immunosensors. Our SERS 
immunoassay system revealed high selectivity among other proteins (avidine, amicase, bovine serum albumin, 
lysozyme, and tryptone). Good reproducibility from ten replications was obtained with a small sample-to-
sample variation of 4.6% (relative standard deviation). To demonstrate the applicability of our SERS 
immunoassay system to real biological samples, the detection of influenza A using infected allantoic fluid was 
also performed. The linear relation between the concentration of infected allantoic fluid and the SERS signal 
was obtained in the range of 5 to 56 TCID50/mL (R2 = 0.96 for the TBBT Raman bands at 1565 cm-1) with the 
least detection limit of 6 TCID50/mL. This finding demonstrated the potential of this SERS immunosensor 
platform for a high sensitive and specific detection of target molecules in a complex matrix commonly found 
in clinical specimens. This work indicates that the sensitivity of SERS immunoassay for influenza A was 
successfully improved by using SERS substrate instead of flat Au substrate.  
Then, the factors determining the sensitivity of SERS immunosensor were clarified. In this study, 
SERS immunoassay was performed using the sandwich format to increase the immobilized and select the 
target antigen density on the SERS substrate. The influence of the SERS probe size and the interparticle gap 
distance between the SERS substrate and probe on the sensitivity of sandwich-type SERS-based 
immunosensors was studied using hydrophilized 2D arrays of Au@Ag NPs as the SERS substrates. The SERS 
probes were the antibody-capped PEGylated AuNPs with different sized Au-core labeled with 4-
mercaptobenzoic acid (MBA). MBA was selected as Raman reporter molecule because of its strong Raman 
bands at 1089 and 1587 cm-1 and ability for antibody immobilization. The SERS signal of MBA at 1587 cm-1 
was used to detect the selective recognition between the target antigen and antibody. To realize the highly 
sensitive detection, the size of SERS probes was optimized by performing a sandwich SERS immunoassay for 
Human-IgG (H-IgG), where the Au-core size of the SERS probe was varied from 26 to 110 nm in diameter. 
The maximum SERS intensity was observed at an Au core size of 53 nm. The optimal probe size was found to 
be determined by the balance between the increase of effective Raman cross-section of a single SERS probe 
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and the decrease of the probe density on the SERS substrate with increasing probe size.   
Next, the influence of the separation distance between the SERS probe and the substrate was examined 
by performing SERS immunoassay for two antigens with different molecular size using the SERS probes with 
Au-core of 53 nm. H-IgG and prostate-specific antigen (PSA) were selected as representative large (12 nm) 
and small (4 nm) antigens. The sensitivity improvement by replacing the flat Au reference substrate with the 
SERS substrate was evaluated for each immunoassay. The sensitivity improvement was 2.3-fold for H-IgG 
and 6.4-fold for PSA. The larger sensitivity improvement was observed for the immunoassay for PSA, which 
is attributed to the smaller immunocomplexes (antibody-antigen-antibody complexes); the shorter separation 
distance between the SERS probe and substrate induces the stronger plasmon coupling. These results indicate 
that the sensitivity of the sandwich-type immunoassay performed on the SERS substrate can be improved by 
adopting a smaller capture- and detection antibodies or antibody fragments for a target antigen. This finding 
provides a guideline for the selection of biomolecular size in the application of SERS immunosensor utilizing 
the combination of SERS probe and SERS substrate. 
In summary, the improvement of the performance of SERS immunoassay by using hydrophilic 2D 
arrays of Au@Ag NPs as a SERS substrate was reported. We found that the sensitivity of SERS immunosensors 
can be improved by replacing the flat substrates with the SERS substrates and also by optimizing the size of 
SERS probes. The degree of sensitivity improvement depended on the size of the biomolecules 
(immunocomplexes). The larger sensitivity improvement was observed for the smaller immunocomplexes.  
This result can be understood by reduction of the separation distance between the SERS probe and the SERS 
substrate; i.e. the smaller immunocomplex results in the smaller separation distance, leading to the stronger 
plasmon coupling between the SERS probe and the SERS substrate. This result suggests that the sensitivity of 
the immunoassay performed on the SERS substrate can be improved by adopting a smaller capture- and/or 
detection antibodies or antibody fragments for a target antigen. The findings obtained in this doctoral program 
research provide a guideline to improve the sensitivity of SERS-based immunosensors.  
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CHAPTER I 
INTRODUCTION 
 
 The increase of death or patients arises from the lack of highly sensitive and specific point-of-care 
(POC) testing devices, such as the devices for glucose detection using enzyme and the test for infectious 
diseases using genetic materials (DNA and RNA) or antibody. The good detection method offers important 
information for helping clinical judgement and treatment decision. The development of disease testing devices 
with low cost, high reliability, sensitivity, selectivity, easy to handle, and no requirement of large amount of 
sample is very helpful for early diagnosis. This is the expectation for the medical profession to decrease the 
number of death and prevent the complication of disease. In past several decades, the high sensitive and 
specific sensors towards early diagnosis have been developed with high accuracy for monitoring the patients. 
Immunoassay is one type of quantitative bioanalytical methods for detecting the proteins or pathogens in 
human body fluid relying on the specific recognition of antigen and antibody [1,2]. These methodologies 
provide many advantages, such as high specificity, sensitivity, and accuracy [3].  Immunoassays have been 
widely applied in many research areas, such as clinical diagnosis and pharmaceutical analysis, and in the food 
industry [2,4]. At the present time, immunoassays are routinely employed in the practical clinical laboratory 
diagnosis to minimize the spread of contagious diseases. The demand for the highly sensitive and trace amount 
analysis for POC diagnosis is increasing. Thus, further improvement of the detection performances (especially 
sensitivity and limit of detection (LOD)) of immunoassays is strongly required. 
 Breakthroughs in analytical readout techniques coupled with immunoassays lead to improvement in 
detection performances [5]. There are attempts using various transducers to perform high sensitive 
immunoassays, such as electrochemical, piezoelectric and fluorescence transducers. Fluorescence transducer 
is the most widely used detection technique for immunoassay, which requires the fluorescent labels 
immobilized on biomolecules. This transducer offers high sensitivity, but it suffers from interferences from 
background signals. Other detection techniques were reported for improving the immunoassay performances, 
e.g. surface plasmon resonance (SPR), microcantilever, and surface-enhanced Raman scattering (SERS). The 
SPR- and microcantilever-based immunoassays are label-free detection methods. In the SPR-based 
2 
 
immunoassay, the antigen is detected by measuring the change of refractive index at the metal surface when 
the antigen or antibody binds on the metal film. This technique has been developed for detection of low antigen 
concentration as well as real-time monitoring. However, this detection is limited for the detection of small 
biomolecules because the small change of refractive index is indistinguishable. In the microcantilever-based 
immunoassay, the antigen-antibody binding events are detected from the resonance frequency shift or bending 
of the microcantilever, which is very sensitive to the mass change on the microcantilever and capable of real-
time detection. However, this technique suffers from the long-term drift of microcantilever bending [5]. In 
past few decades, the improvement of immunoassay performances (sensitivity, and LOD) has been reported 
by employing SERS as a readout method. SERS is the effect that enhances the Raman signal of the molecule 
adsorbed on metal nanostructured substrates. This SERS effect enables the detection of Raman vibrational 
fingerprints of adsorbed molecules and provides ultrasensitive detection up to a single molecule detection. 
SERS offers several advantages over other detection methods, such as no photobleaching, fast, nondestructive, 
high sensitive, high structural selective, and multiplexing detection [6].  
 Recently, immunoassays using metal nanostructures have been developed for improving sensitivity 
through the SERS effect. SERS-based immunoassays combine the specific recognition of antigen-antibody 
and high signal enhancement of the SERS effect. SERS-based immunoassays can be performed as either label-
free or label detection [7,8]. The label-free (intrinsic) SERS immunoassay employs the metal nanostructures 
as solid supports for enhancing the intrinsic Raman scattering of adsorbed biomolecules. The adsorbed 
biomolecule can be directly identified from the measured spectrum [7]. However, this intrinsic detection is 
unable to detect target biomolecules in complex samples containing various kinds of proteins because 
overwhelming background signals from the matrices interfere with the signal of the target biomolecule. To 
improve the specificity of detection and eliminate interference signals, the label (extrinsic) SERS 
immunoassays have been proposed. The amount of target biomolecule is indirectly determined from the signal 
intensity of Raman reporter molecules that are labeled on metal nanoparticles (MNPs). The Raman signal of 
the Raman reporter molecule is significantly enhanced through the localized surface plasmon resonance of 
MNPs [7,8]. To date, the extrinsic SERS immunoassays have been mostly applied in the diagnostic tests for 
infectious diseases, cancers, and tumors. This is because extrinsic detection provides many advantages over 
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conventional fluorescence detection, such as no photobleaching, and narrow spectral width of Raman peaks, 
which can reduce the overlap between different label molecules.   
 In my doctoral program research, a highly sensitive detection method has been developed by 
fabricating SERS-based immunoassay, which is the combination of immunoassay method and SERS readout. 
SERS-based immunoassay employing extrinsic SERS immunoassay platform offers strong potential to a great 
sensitive detection method for the clinical diagnosis. This study has been motivated by the increasing demand 
for highly sensitive and specific detection technique for early disease diagnosis, and SERS immunosensors 
with high sensitivity were fabricated. The applicability of this sensor for detection of cancer biomarker and 
influenza A virus was demonstrated. To fabricate high sensitive SERS-based immunosensors, the hydrophilic 
2D arrays of Au@Ag NPs were used as the SERS substrates instead of flat substrates for increasing the 
sensitivity of immunoassays. The hydrophilicity of these substrates plays an important role in the 
immobilization of the biomolecules. The hydrophilic functional groups (e.g. COOH, and NH2) are used for 
capturing and retaining the biomolecules on the substrates while performing immunoassays. In addition to the 
hydrophilicity, the nanostructure of these substrates is useful for amplifying the Raman signal through the 
electromagnetic field enhancement. The attractive features of our hydrophilic SERS substrates are high particle 
coverage, high uniformity, hydrophilicity, and LSPR tunability to the excitation laser light in the Raman 
measurement. Moreover, to detect target antigen with strong Raman signal and low background signal, SERS 
probes were employed. A variety of SERS probe structures has been reported in many literatures. In our study, 
Au sphere particles, which have been widely used as a core of SERS probe, were employed as the solid support 
because it is easy to synthesize with high uniformity in size and shape. In order to achieve better sensitivity, 
the optimization of SERS probe size should be conducted. By combined use of SERS substrates and SERS 
probes in the SERS immunosensors, the sensitivity enhancement is expected to be obtained through the 
plasmon coupling between these SERS-active materials. Moreover, it has been reported that the size of 
biomolecules, which acts as the barrier between SERS probe and substrate, has an effect on the sensitivity of 
immunosensor. However, improvement of sensitivity by decreasing the size of antibody was still not 
confirmed. Herein, we reported a novel combination of 2D arrays of Au@Ag NPs on ITO substrates, whose 
LSPR was tuned to a He-Ne laser line of 632.8 nm, and immuno Au sphere labeled with Raman reporter 
molecule for detection of Influenza A virus and prostate-specific antigen (PSA). The sensitivity improvement 
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for immunoassay of influenza A and PSA was 4-fold and 6.4-fold, respectively, when performing these 
immunoassay on SERS active substrates. Moreover, we firstly proved that the sensitivity of immunoassays 
was improved by optimizing the size of SERS probe. We found that the maximum sensitivity was obtained by 
using 53-nm probes. We also confirmed the influence of separation distance between SERS probe and substrate 
on the sensitivity improvement. By reducing the immunocomplexes from 36 nm to 28 nm, the sensitivity was 
improved 3-fold.  The objectives of this study are (i) to fabricate the SERS immunosensor using hydrophilic 
2D arrays of Au@Ag core-shell NPs as the SERS substrates and antibody-coated Raman reporter molecule-
labeled AuNPs as the SERS probes for demonstrating influenza A virus detection under real biological 
condition, and (ii) to improve the sensitivity of sandwich type SERS-based immunosensors by optimizing 
SERS probe size, and investigating the influence of separation distance between SERS probe and substrate.   
This dissertation is composed of six chapters. The introduction, the overview of immunoassays, the 
motivation, and objectives of this research, and the structure of this dissertation are presented in this chapter. 
Chapter 2 introduces SERS, immunosensors and SERS-based immunosensors. The synthesis of AuNPs, and 
Au@Ag NPs, the fabrication of ITO, Au, and SERS substrates, the preparation of SERS probes, the 
immunoassay protocol, the instruments, and the characterization methods are written in chapter 3. In chapter 
4, the demonstration of SERS-based immunoassays for influenza A detection relying on direct immunoassay 
format is described. The study on the factors determining the sensitivity of SERS immunoassay is reported in 
chapter 5. The optimization of SERS probe sizes for highest sensitivity enhancement in immunoassays is 
reported. Moreover, the investigation of the influence of separation distance between the SERS probe and the 
SERS substrate on the sensitivity are also described. Finally, in chapter 6, I summarized the major findings in 
this research and discussed the possible future perspective of this research.   
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CHAPTER II 
BACKGROUND INFORMATION 
 
This chapter introduces the surface-enhanced Raman scattering (SERS), immunosensors (immunoassays, 
components of immunoassays, immunoassay formats), and SERS-based immunosensors (types of SERS 
immunosensor, SERS probes, SERS substrates, and characteristic of immunosensors).  
 
2.1 Surface-enhanced Raman scattering (SERS) 
SERS phenomenon was firstly discovered in 1974 by Fleischmann and coworkers who observed the 
enhancement of Raman spectra of pyridine adsorbed on roughened silver electrode [9]. The phenomenon was 
correctly interpreted by Albrecht et al. and Van Duyne et al. in 1977 [10,11]. It was reported that the Raman 
scattering can be significantly enhanced when target molecules adsorbed onto or in close proximity to metal 
nanostructured substrates (Fig. 2-1). Substrates for SERS measurement are typically made of gold (Au) and 
silver (Ag). This is because localized surface plasmon resonances (LSPRs) of these metals lie in the visible 
and near infrared wavelength region, which cover the range of the excitation laser wavelength of Raman 
measurement. By exploiting of the SERS effect, Raman signals of target molecules can be enhanced by several 
orders of magnitude. Therefore, it is possible to detect molecules at low concentrations without label molecules. 
There are two underlying mechanisms to explain the SERS phenomenon: electromagnetic [11] and chemical 
enhancement [10]. The electromagnetic enhancement mechanism (EM) is the dominant enhancement with the 
highest contribution to the enhancement factor by 11 orders of magnitude [12]. EM is caused by the enhanced 
electromagnetic field of metal nanostructures excited by excitation laser. The enhancement is maximized when 
the frequencies of excitation laser and localized surface plasmon resonance (LSPR) of the metallic 
nanostructure (substrate) are properly matched. The LSPR of the metal nanostructure is dependent on the size, 
shape, and type of materials. This EM enhancement is chemically non-selective, but distance-dependent 
[13,14]. The enhancement can vary by several orders of magnitude, depending on the distance between 
adsorbate and substrate. Another mechanism is chemical enhancement mechanism (CM), which originally 
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rises from the charge transfer between adsorbed molecules and metal nanostructured substrates. The charge 
transfer in SERS has been proposed and illustrated in Fig.2-2 [15,16]. Firstly, the electronic state of adsorbed 
molecules is shifted and broadened by their interaction with metal nanostructures. The charge transfer involves 
the transfer from metals to adsorbates or from adsorbates to metals. These interactions lead to signal 
enhancement up to 102 [17]. Until now, SERS has proved as a powerful detection method for investigation of 
the structure and vibrational properties of target molecules adsorbed on metal nanostructures.  
 
 
 
 
 
Fig. 2-1 Schematic illustration of SERS effect.  
 
 
Fig. 2-2 Typical energy level diagram of molecule adsorbed on a metal nanostructured substrate. The 
possible charge transfer excitation is shown by the arrows.  
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2.2 Immunosensors  
Immunosensor, affinity-type biosensor, consists of target analytes (food, environmental, biological samples), 
bioreceptors (antigen-antibody, DNA, aptamer) immobilized on solid support and transducers, which translate 
the signal from the successful reaction between the target analyte and bioreceptors to the detectable data [18]. 
The typical systematic illustration of immunosensor is shown in Fig. 2-3. Immunosensor is the essential 
analytical device in the research areas of clinical diagnostics and point-of-care (POC) testing because it 
provides several advantages including high sensitivity, specificity, and accuracy [3]. Regarding its benefits, 
there is no doubt that immunosensors have been applied in the practical use especially in the medical areas.  
  
 
 
 
 
 
Fig. 2-3 Components of immunosensor. As shown in this figure, there are five steps happen while operating 
immunosensor. All components are important for the performance of immunosensor. The target analyte is the 
specific molecule that expected to detect by immunosensor. The bioreceptor is the antibody or DNA or RNA 
that can specifically bind with a target analyte. The transducer can convert the signal from the successful 
reaction between the target analyte and bioreceptors into a measurable signal. The signal processer is used for 
filtering the signal by canceling noise. Recording and display are used for presenting the data for further 
analyzation process. 
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2.2.1 Immunoassays 
Immunoassay is the analytical method employed in immunosensors for detecting the concentration of 
biomolecule in a sample by specific antigen-antibody recognition. The methodology was firstly developed for 
detecting the insulin in 1960. Immunoassays are still continuously used especially in the health diagnostic labs 
for early diagnosis for several diseases. Moreover, immunoassays have also been employed in the food safety 
and environmental analysis. Immunoassays provide several advantages, such as high specificity and sensitivity. 
However, immunoassays suffer from the high price of antigen and antibody. Immunoassays consist of two 
main components: antigens, and antibodies. The antibody is produced from plasma cell that related to the 
immune system. The antibody can specifically recognize a unique molecule, which is called antigen. The 
information of immunoassay components is given below. 
The antibody is the protein molecule that can specifically identify complementary antigen. The 
antibody or the other name is immunoglobulin (Ig). Immunoglobulin has been classified into five subclasses, 
e.g. IgG, IgE, IgM, IgA, and IgD, which has the different functions in the immune system [19]. The common 
antibody that mostly found in human serum is IgG isotype, which has a flexible Y-shaped structure with 150 
kDa containing 4 polypeptide chains (two heavy chains and two light chains). The two heavy chains are 
connected to each other via a disulfide bond (-S-S-) and the two light chains are also linked with heavy chains 
via disulfide bonds (-S-S-). The structure of an antibody is shown in Fig. 2-4. The Y-shaped antibody consists 
 
Fig. 2-4 Schematic illustration of antibody structure.  
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of three equivalent size parts: two arms and one trunk. The two arms of Y structure are called variable region 
or Fab fragment, where the antigen-antibody binding occurs. Each antibody is designed to react with particular 
antigen due to the difference of amino acid sequence at Fab fragment. The trunk of antibody is named a 
constant region or Fc region, which cannot bind with antigen but can react with macrophages, natural killer 
cells and neutrophils [20]. The antibodies have two types: monoclonal and polyclonal antibodies. Monoclonal 
antibodies have a monovalent affinity with a single binding site of antigen. Whereas, polyclonal antibodies 
can bind to multiple binding sites of antigen. For high specific recognition of target analyte, the monoclonal 
antibodies are preferably used.  
Antigen stands for Antibody Generator, which was proposed by Paul Ehrlich; German Scientist. The 
antigen is the molecule that can stimulate an immune response and antibody on the host after entered or created 
by host’s body. The molecules that can act as an antigen are glycoproteins in or out plasma membrane, peptides, 
polysaccharides, nucleic acids, and lipids. The antigen can be specifically captured by the complementary 
antibody.  
The antibody interacts with antigen via a lock and key model. The strength of reaction is referred to 
the affinity of reaction, which is determined by the binding strength between antigen’s epitope and antibody’s 
paratope (Fab fragment). The epitope is the binding site of antigen, while the paratope is the binding site of an 
antibody [19]. Fig. 2-5 shows the epitope of antigen and paratope of antibody. There are many forces get 
involved in the interaction of antigen at Fab fragment of an antibody, i.e. electrostatic force, hydrogen bonds, 
hydrophobic interaction and van der Waals force. These forces are weak, which makes the reversible antigen-
antibody bond. This reaction is not only reversible but also accept the law of mass action, for example, the 
reaction rate is proportional to the concentration of antigen and antibody. The equilibrium constant (Kaq) or 
the affinity constant of antigen (Ag)-antibody (Ab) interaction can be calculated as shown in equation 1. At 
equilibrium, the ratio of the concentration of product (antigen-antibody complex) and reactants (antigen and 
antibody) is constant. The affinity of antigen-antibody interaction depends on not only the aforementioned 
forces but also the pH, temperature, concentration and ionic strength of electrolyte, type of antigen and 
antibody [21]. The value of Kaq of antigen-antibody recognition normally falls in the range of 106-1012 M-1 
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[22]. The higher affinity of immunoassay system results in irreversible interaction between antigen and 
antibody.  
Ab + Ag ↔ Ab. Ag                 , 𝐾𝑎𝑞 =
[𝐴𝑏. 𝐴𝑔]
[𝐴𝑏][𝐴𝑔 ]
… … … … … … … … … . (1) 
 
2.2.2 Immunoassay formats 
Immunoassays have two main platforms that depend on the separation process of unbound biomolecules from 
the reaction [23]. The homogeneous immunoassay, such as agglutination, capillary electrophoresis, 
fluorescence polarization, and fluorescence-resonance energy-transfer-based immunoassay, do not require any 
separation process. Another platform is called heterogeneous immunoassay, which requires the separation of 
unbound molecules from immunocomplexes. In this platform, immunoreagents have to immobilize on a solid 
support, which is convenient for removing unbound molecules. The specifically bound target antigen can be 
only measured without any contaminations. The materials used as supporting substrate for immobilizing 
biomolecule (e.g. antigen, antibody, DNA) play a crucial role for the binding affinity of the biomolecule. 
Immunoassays performed on the substrates can be carried out with four ways of formats, such as direct, indirect, 
sandwich, and competitive immunoassays. The format selection for immunoassay depends on the dynamic 
range of analytes and sensitivity of detection.  The schematic illustrations of reaction steps of all immunoassay 
formats are shown in Fig. 2-6 to 2-9 and the details of each format are described below.   
 
 
 
Fig. 2-5 Binding event of epitope of antigen and paratope of antibody.  
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A. Direct immunoassay  
The direct immunoassay is the simplest immunoassay format. For direct immunoassay, the antigen is directly 
immobilized on a solid substrate and it is detected by monitoring the signal from added primary antibody 
conjugate (Fig. 2-6). This model is good for quick detection with few step of immunoassay and no cross-
reaction from secondary antibody. However, no commercial kits are available because it provides some 
disadvantages; (i) primary antibody is expensive, (ii) signal amplification is low [23].  
 
B. Indirect immunoassay  
For indirect immunoassay, the protocol is similar with direct immunoassay with one more additional step of 
polyclonal antibodies.  Therefore, the immobilized antigen is detected with two types of antibodies. The non-
labeled primary antibody is first added to specific bind with antigen. Then, the labeled secondary antibody is 
added for binding with the primary antibody (Fig. 2-7). The type of secondary antibody that often used is a 
polyclonal antibody. This indirect format is mostly used for ELISA because (i) secondary antibody can widely 
use for binding with many kinds of primary antibody, (ii) the sensitivity can be enhanced via the signal 
amplification from the several binding sites of the secondary antibody on several epitopes of the primary 
antibody. However, this immunoassay model has some disadvantages about the prolongation of detection time 
due to one more addition step and the non-specific signal due to the cross-reaction of the secondary antibody.  
 
Fig. 2-6 Diagram illustration of the immunoreaction steps leading to the final binding structures for 
direct immunoassay using detection antibodies. 
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C. Sandwich immunoassay 
Sandwich immunoassay consists of one antigen and two antibodies, which has high antigen specificity. The 
antigen is sandwiched between two antibodies. The first antibody, namely capture antibody, is firstly 
immobilized on the substrate. Then, the antigen is injected for binding with capture antibody. Next, another 
antibody (detection antibody) is added to bind with antigen. These two antibodies are bound to an antigen with 
different epitope. The signal is measured from the secondary antibody [23]. The signal of detected secondary 
antibody corresponds to the concentration of target antigen. The reaction steps in the sandwich immunoassay 
are shown in Fig. 2-8. The advantages of this platform are high specificity, suitable for complex samples, e.g., 
crude, blood without purification process.  
 
Fig. 2-7 Diagram illustration of the immunoreaction steps leading to the final binding structures for 
indirect immunoassay using polyclonal antibodies as secondary antibodies.  
 
Fig. 2-8 Diagram illustration of the immunoreaction steps leading to the final binding structures for 
sandwich immunoassay using capture and detection antibodies.  
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D. Competitive immunoassay 
The competitive immunoassay or inhibition immunoassay is the competitive reaction between the target 
antigen and labeled antigen to bind to the primary antibody that immobilized on the substrate. Firstly, the 
primary antibodies are immobilized on the substrate to selectively bind with the target antigen. Then, the fixed 
amount of labeled antigen and variable amount of target antigen are mixed. The mixed solution is dropped and 
incubated on the substrate, leading to antigen-antibody complexes formation. At this step, the labeled antigen 
and target antigen compete to bind with the primary antibody. Then, the unbound labeled antigen and target 
antigen are washed away by washing process [23]. Figure 2-9 shows the immunoreaction steps leading to the 
final binding structures of competitive immunoassay. The signal from labeled antigen after bind primary 
antibody is measured, which is represent the total amount of labeled antigen and target antigen. As the 
concentration of target antigen increases, less amount of labeled antigen can bind to antibody and the 
measurable signal decreases. The lower signal of labeled antigen, the higher concentration of target antigen. 
The calibration curve of this immunoassay has a negative slope, which is drawn in Fig. 2-9. This immunoassay 
format is suitable for detecting target antigen from complex samples due to its high specificity. However, this 
format is not commonly used because it is complicated.  
 
 
 
 
Fig. 2-9 Diagram illustration of the immunoreaction steps leading to the final binding structures for 
competitive immunoassay using labelled antigens.  
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2.2.3 Transducers for immunosensors 
Transducers are the devices to convert the signal generated from the formation of antigen-antibody complexes 
to a measurable signal. There are three main types of transducers have been applied in immunosensors, such 
as electrochemical, piezoelectric, and optical transducers. The basic of different transducer techniques 
employing in immunosensors are given below.  
 
A. Electrochemical transducers  
The electrochemical transducers are combined with the immunosensors to convert the event of antigen-
antibody recognition into electrical signals, such as the change of current, potential, and electrical conductivity 
[24]. Since the immunoreaction are detected near the surface of electrodes, electrodes play an important role 
in the performance of electrochemical immunosensors. In electrochemical detection, three kinds of electrodes 
are required: a working electrode, a reference electrode, and a counter electrode [25]. The working electrode 
uses as transduction element, where the recognition between antigen and antibody occurs. The reference 
electrode, typically made from Ag/AgCl, has stable and known electrode potential. The counter electrode 
establishes electrical potential connected to the working electrode. The main electrochemical transducers 
applied in immunosensors are amperometric (measuring of current), potentiometric (measuring of voltage or 
potential difference between the working electrode and reference electrode), and conductimetric transducers 
(measuring of conductivity or resistance). Figure 2-10 shows an example of electrochemical immunosensor 
for detection of P. falciparum histidine-rich protein related to malaria using magnetic nanoparticles-coupled 
graphite-epoxy composite as a working electrode and Ag/AgCl electrode as a reference electrode [26]. The 
immunoassay for malaria was performed by adopting sandwich immunoassay on the working electrode. IgM 
monoclonal antibodies were used as capture antibodies deposited on the working electrode and IgG antibodies 
labeled enzyme horseradish peroxidase (HRP) were served as detection antibodies. Based on the redox reaction 
of HRP enzyme after adding hydrogen peroxide, the electrochemical signal was detected, which corresponds 
to the amount of P. falciparum histidine-rich protein. This electrochemical immunosensor shows detection 
limit of 0.36 ng/mL. Electrochemical detection has the potential for applying in the detection of diseases 
because of its advantages, such as simple, low cost, and non-destructive detection. However, this detection 
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method has suffered from a lack of surface architecture of working electrode for improving sensitivity and 
specificity [27]. Therefore, the integration of nanotechnology with working electrode offers a possible way to 
improve the sensitivity of detection.  
 
 
B. Piezoelectric transducers 
Piezoelectric transducers can directly detect the change of mass during the immunoreaction between antigen 
and antibody occurs. Piezoelectric transducers are used in immunosensors, such as microcantilevers and quartz 
crystal microbalances. For this transducer, the antibody is immobilized on the surface of piezoelectric 
substrates and the antigen in the solution is capture by immobilized antibody. These antigen-antibody 
complexes are detected as resonant frequency shift, which is sensitive to the mass changes on substrates [28,29]. 
An example of piezoelectric immunosensor performed on microcantilever is shown in Fig. 2-11 [30]. The first 
piezoelectric immunosensor was originated by Shons et al [31] to detect bovine serum albumin (BSA) using 
9 MHz piezoelectric crystal. They succeeded in detecting BSA in short detection time with good sensitivity 
comparable to the conventional technique of passive agglutination, which required many hours for detection. 
Piezoelectric immunosensors have been further developed for detection of meaningful analytes, such as 
microbial pathogen [32-34], immunoglobulin [35], and human chronic gonadotropin (hCG) [36]. Piezoelectric 
immunoassays have been performed with high sensitivity and without labeling molecule and secondary 
 
Fig. 2-10 Schematic illustration of the electrochemical detection of sandwich immunoassay for 
detection of P. falciparum histidine-rich protein.  
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antibodies. However, nonspecific adsorption may possibly happen, which interferes with the target antigen 
signal and reduce the reliability of the detection [37]. The development to eliminate the nonspecific adsorption 
from piezoelectric immunoassays is still required. The modification of the immobilization processes may 
improve the sensitivity and selectivity of the sensor.  
 C. Optical transducers 
Optical transducers are used to convert the light interacted with biological elements to the electronic signals. 
In the optical immunosensors, the biomolecules are immobilized on the surfaces connected to the transducer 
and the interaction between antigen and antibody is detected by the change of optical signals, such as 
absorbance, reflectance, emission, refractive index. Optical signals are collected by the photodetector and 
converted to electrical signals. There are many kinds of optical signals/phenomena employed in the optical 
immunosensors, which are summarized in Table 2-1 [38]. Optical detections can be classified into two types 
regarding the direct and indirect detection of antigen-antibody recognition [39]. The direct (label-free) 
detections directly measure the signal generated from the antigen-antibody interaction. The label molecules 
are not required in these methods. These techniques are limited to detect the small biomolecules. They have 
suffered from the non-specific adsorption of the biomolecule. The main types of transducers available for 
 
Fig. 2-11 Schematic illustration of microcantilever immunoassay. The formation of the antigen-antibody 
complexes provokes a surface stress and, consequently, a deflection of microcantilever, which is detected 
optically.  
 
18 
 
direct optical detections are surface plasmon resonance (SPR), grating-couplers, and Mach-Zehder 
interferometers [40-42]. The mostly used transducer employed in direct optical immunoassays is SPR because 
of its high sensitivity. The SPR immunosensor has been developed to directly detect the antigen binding to an 
antibody immobilized on the SPR sensor surface, which is capable of detecting target antigen in a complex 
biological fluid with highly sensitive, specific and repeatable detection. The target antigen is detected through 
the shift of SPR angle [43]. The SPR immunosensor has been developed for detection of low antigen 
concentration as well as real-time monitoring. However, this signal interferes from an artifactual change of 
refractive index, which is the false-positive signal. 
 In the case of indirect optical detections, the labeling process of label molecules on the antigen or 
antibody is required. The signal from the labels is proportional to the amount of the target analytes in the 
samples. These label detections can improve the sensitivity and specificity of the sensors. The transducers 
exploited in the indirect optical detections are fluorescence and SERS. The most widely used optical 
immunosensor to realize protein detection with high sensitivity is the fluorescence immunosensor, which 
employs the fluorescent-labeled antibody to recognize the target antigen [44]. The amount of antigen can be 
determined by measuring the fluorescent signals of the fluorescent molecules. The fluorescence immunoassays 
are rapid and high sensitive detection method. However, there has been reported some disadvantages, such as 
rapid photobleaching of fluorescent molecule, and activity loss of biomolecule upon the chemical interaction 
with a fluorescent molecule [45]. To overcome the disadvantages of fluorescence detection, SERS has been 
employed as a transducer in the immunosensors. SERS employs Raman reporter molecule labeled-metal 
nanoparticles (MNPs) decorated with antibodies (SERS probes) as Raman signal generators. Raman reporter 
molecules provide advantages over the fluorescence labels, such as no photobleaching and 10-100 times 
narrower spectral width [8]. Recently, SERS-based immunosensors have attracted much attention due to its 
high sensitive detection through the electromagnetic field enhancement from metal nanostructures [46]. This 
SERS readout technique has the potential to detect antigen up to a single molecular level. Among other 
transducers for immunoassay, SERS shows many merits, such as inherent molecular specific, high sensitive, 
and rapid detection, over other detection techniques. Based on the advantages of SERS, the fabrication and 
demonstration of highly sensitive immunoassay adopting SERS as a readout technique have been reported in 
this dissertation. The background information of SERS immunosensors is described in the next section.     
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Table 2-1. Optical signal/phenomena employed in optical immunosensors.  
Optical signal/property Transducing technique 
Absorbance Light intensity measurement 
Reflectance Light intensity measurement 
Fluorescence Total internal reflection fluorescence 
Refraction index Interferometry 
Surface plasmon resonance (SPR) 
Total internal reflection 
Optical path Interferometry 
Spectroscopies Surface-enhanced Raman scattering (SERS) 
 
2.3 SERS-based immunosensors 
 The SERS-based immunosensor is the combination between the immunosensor device and the 
surface-enhanced Raman scattering (SERS) readout technique. SERS immunosensors are used in the detection 
of various biological samples, such as urine, plasma, etc. In SERS immunosensors, the signal of the antigen-
antibody recognition is enhanced by the electromagnetic field enhancement of the metal nanostructures. By 
taking the advantage of both immunoassay (high reaction affinity) and SERS (high signal enhancement), the 
SERS immunoassay has been developed to perform the high sensitive and selective detection technique. 
Typically, SERS-based immunosensors were classified into two types: intrinsic and extrinsic immunosensors.  
 
2.3.1 Intrinsic SERS immunosensors  
In the intrinsic detection, Raman scattered light from bioanalyte is directly detected with the help of the 
electromagnetic field enhancement effect of SERS. The detected signals are relatively straightforward for the 
target molecules. Intrinsic detection is suitable for the detection of molecules has a small number of vibrational 
modes, such as small protein, lipids, and DNA [8]. For instance, the detection of DNA on gold nanoshell 
deposited glass substrate [47], a protein linked between AgNPs [48], and bombesin, tumor marker, adsorbed 
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AgNPs [49] were achieved. The illustrations of intrinsic SERS immunoassay performed on the metal 
nanostructured substrates and in a colloidal solution of gold nanoparticles (AuNPs) are shown in Fig. 2-12. 
The intrinsic detection has suffered from the detection of large molecules and complex systems that contain a 
lot of biomolecules. Since different kinds of proteins have common basis components, their Raman spectra 
should contain similar vibrational bands, e.g. COO- stretch at 1400 cm-1, aromatic NH2 at 950 cm-1, broad 
amide (CO-NH) I and III bands at 1600-1700 cm-1, and 1200-1350 cm-1 [8]. Therefore, it is difficult to make 
a distinction between different kinds of proteins (biomolecules) from the Raman spectra.   
 
2.3.2 Extrinsic SERS immunosensors  
Extrinsic SERS immunosensor has been developed to overcome the limitation of intrinsic SERS 
immunosensor, in which a target bioanalyte labeled with a Raman reporter molecule that has unique vibrational 
fingerprints is used. In general extrinsic detection methods, target bioanalytes are first immobilized on 
substrates, and then SERS probes containing Raman reporter molecules are selectively immobilized on the 
target bioanalytes. The existence of bioanalytes is indirectly recognized by detecting the signal from the Raman 
reporter molecules. Therefore, this extrinsic detection can be applied to complex systems that contain a lot of 
biomolecules.  
 In the first generation of extrinsic detection, the immunoassay reaction was performed on flat 
substrates, e.g. Au or glass substrates [50,51]. Since no electric field enhancement can be expected from such 
a flat substrate, the enhancement of Raman signal comes from the electromagnetic field enhancement effect 
 
Fig. 2-12 (a) Intrinsic SERS immunoassay of small protein adsorbed on metal nanostructure substrate, and 
(b) intrinsic detection of DNA in colloidal solution of gold nanoparticles.  
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of the center metallic NPs composing SERS probes and/or from that due to plasmonic coupling among SERS 
probes. The illustration of extrinsic SERS immunoassay on a flat substrate is shown in Fig. 2-13. There are 
two strategies for improving the sensitivity of extrinsic detection. One is the structure design of SERS probes; 
for instance, higher electromagnetic field enhancement can be obtained by using Au nanoflowers, Au nanostars, 
or aggregates of AuNPs as the center metallic NPs of SERS probes, instead of sphere-shaped AuNPs [52]. 
Another strategy is the use of a nanostructured metallic substrate (SERS substrate) instead of a flat substrate. 
By properly designing the SERS substrate, significant improvement in the sensitivity can be expected through 
strong plasmon coupling between SERS substrates and SERS probes. According to these strategies, some 
groups reported good achievements on SERS biosensors. Kaminska and coworkers [53] reported a 
microfluidic SERS immunosensor for Hepatitis B virus detection, where an Au/Ag-coated GaN substrate was 
used as a SERS-active substrate and basic fuchsin-adsorbed Au nanoflowers were used as SERS probes. This 
system reveals good performance with high specificity and low detection limit about 0.01IU/mL. Pei and 
coworkers [52] achieved high sensitive SERS immunoassay by using self-assembled gold nanostars substrate 
as a SERS substrate and aggregates of gold nanostars as SERS probes. The low detection limit about 10 fg/mL 
was obtained for immunoassay of anti-goat human IgG and human IgG. Such a very low detection limit of this 
model may be caused by the strong plasmonic coupling between the SERS probe and substrate [46]. Therefore, 
the development of SERS substrates that can be electromagnetically coupled with SERS probes and also that 
shows high reproducibility is crucial for realizing high sensitive biosensors.  
Since extrinsic SERS immunosensors consist of two important components: SERS probe and substrate, 
the general information of these materials were briefly explained as follows. 
 
Fig. 2-13 Illustration of extrinsic sandwich-type SERS immunoassay performed on flat solid substrate.  
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A. SERS probes  
SERS probes are noble MNPs loaded with Raman-active molecules, which has high and distinctive vibration 
fingerprint, for identifying bio-targets using their own inherent Raman fingerprint. Typical SERS probes 
consist of MNPs, Raman reporter molecules, protecting shell, and specific targeting molecules [54,55]. The 
MNPs act as SERS-active support for Raman reporter molecule. These particles are the biocompatible 
materials that mostly applied for biomedical applications. Raman reporter molecules are the thiolated 
molecules that can chemisorb on the MNPs and produce strong and unique Raman spectra. The typical Raman 
reporter molecules are listed in table 2-2. Protecting shell, used for MNPs stabilization and avoided desorption 
of Raman reporter, has many kinds of chemical, such as SiO2, TiO2, polymer. These chemicals are able to 
decorate with a biomolecule (antibody, DNA, and aptamer) for selective binding with target analytes [56]. The 
general steps of SERS probe synthesis and design are shown in Fig. 2-14 [57]. Briefly, the MNPs with desired 
particle size, shape and LSPR is selected. Then, the MNPs are labeled with Raman reporter molecules via the 
metal-S bond. These particles are stabilized by coating with polymers. Finally, the antibodies are immobilized 
on the particles via covalent bonds. The SERS probes should have large effective Raman cross-section with 
the selective binding ability to a target bio-analyte and sufficient stability in air and aqueous solution. By 
designing metallic NPs properly, the scattering efficiency of Raman reporter molecules can be strongly 
enhanced via LSPR of the MNPs. Using biocompatible SERS probes, the extrinsic detection can be applied to 
cellular and in vivo sensing: e.g. local pH mapping in cell and detection of cancer markers in a live cell 
[54,8,58].  
 
Fig. 2-14 General steps and designs of SERS probes for biomedical applications.  
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Table 2-2 Typical Raman reporter molecule in SERS probe synthesis 
Type Example Linking mode Advantages Disadvantages 
Cationic 
dye 
Rhodamine 6G 
Nile blue  
N-Au or Ag 
(electrostatic 
force) 
-Cheap  
-Large Raman cross-
section 
- Weak bonding 
to metal 
Thiol 
molecule 
4-mercaptobenzoic acid  
4-aminothiophenol 
4-thionitrophenol 
S-Au or Ag -Cheap 
-Strong bonding to metal  
- Small Raman 
cross-section 
 
Thiol dye Malachite green 
isothiocyanate 
Rhodamine-5-(and-6)-
isothiocyanate 
S-Au or Ag -Large Raman cross-
section 
-Strong bonding to metal 
- Difficult to form 
SAMs  
 
B. SERS substrates  
SERS substrates are the metal nanostructured substrates, which mostly fabricated from silver (Ag) and gold 
(Au). The large electromagnetic field enhancement could be obtained from SERS substrates when the LSPR 
of substrates is properly matched with the wavelength of excitation laser [59,60]. SERS substrates can be 
fabricated by using various kinds of fabrication processes, such as lithography [61], self-assembled monolayer 
[62], electrochemical deposition, atomic layer deposition [63], laser printing, and nanoimprinting technique. 
The lithography and atomic layer deposition require high cost, the skilled person, but it shows the uniform size 
and shape. On the other hand, a self-assembled monolayer is easy to handle and cheap, but uncontrollable size 
and shape are found. Figure 2-15 shows the scanning electron microscope images of some SERS substrates 
fabricated using various kinds of the fabrication processes, such as (a) metal film deposited over nanosphere 
[64], (b) metal island deposited on sphere mask [63], (c) two-dimensional (2D) array by electron beam 
lithography [61], and (d) 2D nanoholes by atomic layer deposition[64], and (e) self-assembled monolayer of 
AuNPs capped alkanethiol [62]. 
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The ideal SERS substrate for all kinds of applications should possess high uniformity, high field 
enhancement, reproducible SERS enhancement, stable, and biocompatibility [65]. In past few decades, the 
SERS substrates have been employed for amplifying the signals in immunoassays. In the case of SERS 
substrate for immunoassay, it not only shows the strong electromagnetic field enhancement but also presents 
the chemical group for chemically binding with a biomolecule. The use of SERS substrate in immunoassays 
offers a great promise for trace amount detection with high sensitivity [66,67].  
 
 
 
 
 
 
 
 
Fig. 2-15 Scanning electron microscope image of various SERS substrate fabrication process. (a) metal 
film deposited over nanosphere [64], (b) metal island deposited on sphere mask [63], (c) 2D array by 
electron beam lithography [61], and (d) 2D nanoholes by atomic layer deposition [64], and (e) self-
assemble monolayer of AuNPs capped alkanethiol [62]. 
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CHAPTER III 
EXPERIMENTAL 
 
The chemicals, biomolecules, the characterization equipments and the characterization methods employed in 
this research are described in this chapter. The chemicals and biomolecules are given in the first part. The 
molecular structures of some chemicals are shown in Fig. 3-1. Next, the preparation of substrates (gold (Au) 
and indium tin oxide (ITO)), gold nanoparticles (AuNPs), gold core@silver shell nanoparticles (Au@Ag core-
shell NPs), and hydrophilic SERS substrates are explained. Then, the instruments and the measurement 
conditions are described. Finally, the characterization methods of SERS immunosensor are described.  
  
3.1 Chemicals and biomolecules 
Chloroauric acid (HAuCl4), 4,4’-thiobisbenzenethiol (TBBT), 1-ethyl-3[3-dimethylaminopropyl] 
carbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS), mercaptohexadecanoic acid (MHDA), 
mercaptobenzoic acid (MBA), polyoxyethylene (20) sorbitan monolaurate (Tween 20), disodium 
hydrogenphosphate (Na2HPO4), potassium dihydrogenphosphate (KH2PO4), and sodium chloride (NaCl) were 
obtained from Sigma-Aldrich. Silver nitrate (AgNO3), sodium citrate, ascorbic acid, dodecanethiol, and 
octadecanethiol were purchased from Nacalai tesque. Polyethylene glycol methyl ether thiol (PEG-SH, MW 
5,000 Da), and polyethylene glycol 2-mercaptoethyl ether acetic acid (COOH-PEG-SH, MW 3,400 Da) were 
obtained from Nanocs, Inc. Bovine serum albumin (BSA) was purchased from Wako. The commercially 
available chemicals were used without further purification. Phosphate buffered saline (PBS) solution was 
prepared by mixing Na2HPO4, KH2PO4, and NaCl: one liter of 10 mM PBS solution includes 2.17 g of 
Na2HPO4, 0.26 g of KH2PO4, 8.71 g of NaCl. Distilled water (18.2 MΩ. cm) was used in all experiment.  
For influenza A detection, a monoclonal antibody specific to influenza A nucleoprotein was purchased 
from Innova Biotechnology and used without further purification. The allantoic fluid infected with Influenza 
A/Thailand/104/2009 (H1N1) (Prof. Pilaipan Puthavathana, Mahidol University, Bangkok, Thailand) was 
prepared and inactivated as described [68]. The recombinant nucleoprotein used in this study was generated 
and characterized as described previously [69]. For dilution of the infected allantoic fluid, an extraction buffer 
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solution (150 mM NaCl, 5 mM EDTA, 16 mM Triton X-100, 12 mM sodium deoxycholate, and 3.5 mM SDS 
in 10 mM phosphate buffer pH 7.4) was used as the solvent.  
For immunoglobulin G (IgG) detection, Goat anti Human-IgG (# 31119, Mw 150 kDa) was purchased 
from Thermo scientific. Purified human-IgG (# P80-105, Mw 150 kDa) was bought from Bethyl laboratories, 
Inc. For prostate specific antigen detection, monoclonal capture antibody to PSA (clone M12619PS1, # 10-
P142A, Mw 150 kDa), monoclonal detection antibody to PSA (clone M18612PS4, # 10-7948, Mw 150 kDa), 
and PSA antigen (clone A15052982, # 30C-CP1017U, >98% pure, Mw 30 kDa) were provided by Fitzgerald. 
Fig. 3-1 Molecular structures of chemicals 
Chemical name Molecular structure 
1-ethyl-3[3-dimethylaminopropyl] 
carbodiimide hydrochloride (EDC) 
 
N-hydroxysuccinimide (NHS) 
 
Mercaptohexadecanoic acid (MHDA)  
Mercaptobenzoic acid (MBA) 
 
Aminopropyl trimethoxysilane (APTES) 
 
Thiolated PEG carboxylate;  
HS-PEG-COOH (MW = 3,400 Da) 
 
Thiolated PEG; HS-PEG (MW = 5,000 Da) 
 
4, 4’-thiobisbenzenethiol (TBBT) 
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3.2 Sample preparation 
3.2.1 Substrates  
ITO substrate: 0.6 mm-thick quartz were used as a substrate with 1cm1 cm. Substrates were immersed in 
piranha solution (30% H2SO4/H2O2=2:1 v/v) for cleaning organic matter on the substrate and rinsed with milli-
Q water three times. Then substrates were coated with ITO by radio frequency sputtering deposition at room 
temperature. Before functionalized substrate, UV-ozone cleaning was done for 3 h (final bulk resistivity of 
1.110-3 .cm), followed by immersing in 1% (v/v) solution of 3-mercaptopropyltrimethoxysilane in toluene 
for 40 h, rinsed with toluene and methanol three times. Ultimately, substrates were immersed in 1% (v/v) 
solution of 1, 6-hexanedithiol in ethanol for 12h, rinsed with isopropanol three times and dried with N2 stream. 
Au substrate: Before Au film deposition, 0.6 mm-thick quartz substrates were immersed in piranha solution 
to remove organic matter and then rinsed with milli-Q water three times. A 10 nm-thick Cr adhesion layer 
and a 40 nm-thick Au film were sequentially deposited on the quartz substrate by thermal evaporation in a 
vacuum (<10-4 Pa). The deposition rate of both Cr and Au was 0.1 nm/s. 
 
3.2.2 Citrated-capped AuNPs 
Citrate-capped AuNPs of different sizes were synthesized by a seed-mediated growth method [62]. Firstly, a 
colloidal solution of Au seeds of 13 nm in diameter was synthesized as follows; 20 mL of a 0.5 mM aqueous 
solution of HAuCl4 was refluxed, and then 1 mL of a 38.8 mM aqueous solution of sodium citrate was added 
to the boiling solution; and the solution was refluxed for 30 minutes at 120C to complete the reaction. Next, 
AuNPs of different particle sizes were synthesized as follows; the colloidal solution of Au seeds, whose 
volume was varied depending on the target particle size as listed in Table 3-1, was mixed with 34 mL of 
deionized (DI) water in a vessel while stirring constantly; then 0.8 mL of a 20 mM aqueous solution of HAuCl4 
and 80 µL of a 10 mM aqueous solution of AgNO3 were added in series; after the solution was mixed for a 
few minutes, 6 mL of a 5.3 mM ascorbic acid aqueous solution was added with a constant feeding rate of 0.61 
mL/min; to complete the reduction, the solution was stirred for 5 min after the addition of ascorbic acid 
solution; and then a solution of citrate-capped AuNPs was obtained. 
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Table 3-1. Amount of colloidal solution of Au seeds used for synthesizing AuNPs of different sizes. 
Diameter of AuNPs (nm) 13 nm-Au Seed solution (mL) 
26 5.0 
31 3.0 
42 1.3 
53 0.6 
77 0.2 
110 0.1 
 
3.2.3 2D arrays of 42Au@Ag core-shell NPs 
The SERS substrates used in this study are 2D arrays of Au@Ag NPs formed on ITO substrates. First, Citrate-
capped Au@Ag core-shell nanoparticles were synthesized as follows [70]. 15 mL of 42 nm gold colloidal 
solution prepared according to the recipe described in the previous section was added to 13 mL of water 
containing 1.2 mL of 10 mM ascorbic acid, then a 1.2 mL of 5 mM AgNO3 solution was added with feeding 
rate of 0.4 mL/min. After completely adding AgNO3, the solution was continuously stirred for 5 minutes to 
complete reaction. The Au core diameter and the Ag shell thickness were determined to be 42 nm and 5 nm, 
respectively. The structure of Au@Ag NPs was designed so that the LSPR energy of 2D Au@Ag NP arrays 
matches the excitation wavelength (633 nm) of the Raman measurement in this study.  Then, alkanethiolate-
capped Au@Ag NPs were synthesized according to the procedure reported previously,[70] except for using a 
mixed solution of octadecanethiol: dodecanethiol = 1:6 (molar ratio) in acetone [71] for the mixed self-
assembled monolayer (SAM) formation on the Au@Ag NP surface. The details of Au@Ag NP synthesis were 
described below. The citrate-capped Au@Ag NPs were thiolated as follows. A mixed solution of 
dodecanethiol and octadecanetiol in acetone was prepared at a molar ratio of dodecanethiol:octadecanethiol = 
6:1 and at a total alkanethiol concentration of 11.3 mM. 10 mL of this mixed alkanethiol solution was gradually 
added to 10 mL of the citrated Au@AgNPs colloidal solution while stirring. Then, this stirring was continued 
at RT overnight, until the solution became clear and Au@Ag NPs were floated. To collect mixed-
alkanethiolate-capped Au@Ag NPs, a mixture of acetone and n-hexane was added to the colloidal solution. 
The thiolated Au@AgNPs concentrated at the interface between the hexane and acetone/water layers were 
collected with a pipette. This collection process was performed repeatedly until no Au@Ag NPs appeared at 
the interface. The collected particles were washed by three cycles of centrifugation and redispersion into a 
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mixture of acetone and n-hexane; the acetone/hexane ratio was sequentially varied: 10:0, 1:9, and 0:10.  After 
the supernatant was discarded in the final washing cycle, the Au@Ag NPs were dried under a nitrogen 
atmosphere.  Before arraying process, the powder of Au@Ag NPs was redispersed in 2 mL of a mixture of 
hexane-acetone (4:1 v/v).  
The alkanethiolate-capped Au@Ag NPs were arrayed on an ITO substrate by a hybrid method, in 
which uniform and high coverage 2D arrays of metallic NPs are formed through solvent-evaporation-induced 
self-assembly under the presence of electric field.[72,73] Before arraying Au@Ag NPs, the ITO substrate was 
successively functionalized with 3-mercaptopropyl trimethoxysilane (MPTMS) and 1,6-hexanedithiol. The 
colloidal solution of mixed alkanethiol-capped Au@Ag NPs redispersed in 2 mL of a mixture of hexane-
acetone (4:1 v/v) was added into a vessel. A thiolated ITO substrate and a plastic formed carbon electrode 
were immersed into the vessel and used as a cathode and an anode, respectively. The distance between these 
electrodes was set at 1.2 mm. The Au@Ag NPs immobilized on thiolated ITO substrate after applying a voltage 
of 1 V at room temperature under nitrogen environment. The arraying of Au@AgNPs was completely done 
after solvent entirely evaporated. Afterward, the 2D array samples were annealed at 60C overnight to enable 
chemisorptions of Au@Ag NPs on the functionalized ITO substrate, and then washed by sonication in hexane 
for 30 s to remove excess of Au@Ag NPs.  
 
3.2.4 Hydrophilic SERS substrate  
Since the 2D array substrate obtained by this method is hydrophobic, it is not suitable for immunoassays. Thus, 
the 2D array substrate was hydrophilized by exchanging the capping molecules with MHDA. First, the 2D 
array substrate was annealed at 90C for 1 h.  We believe that most of alkanethiolate molecules adsorbed on 
the upper half (air side) of Au@Ag NPs are desorbed during this annealing. Then the substrate was immersed 
in an ethanolic solution of MHDA (15 mM) for 12 h at 50C. The substrates were rinsed with ethanol three 
times and dried under a nitrogen atmosphere.  
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3.2.5 Activation of SERS substrate  
Before utilizing the hydrophilic SERS substrate as the solid support for immunoassay, the activation of 
carboxyl portion of MHDA molecule for further interaction with biomolecule was performed by using the 
mixture of EDC-NHS crosslinking molecules. The freshly prepared hydrophilic SERS substrate was activated 
by successively dropping 10 µL of a 15 mM EDC aqueous solution and 10 µL of a 15 mM NHS aqueous 
solution. The mixed droplet was kept on the substrate for 30 min in the dark chamber. Then, the substrate was 
washed with distilled PBS solution three times and dried by nitrogen gas. The mechanism of the reaction 
between the carboxyl group and EDC/NHS crosslinking molecules is shown in Fig. 3-2.  
 
3.3 Instruments 
The morphology of AuNPs was characterized by SEM, TEM, and EDX. SEM images were obtained with FE-
SEM S-4800 (Hitachi, Japan) to evaluate the morphology and coverage of particles on the substrate with an 
accelerating voltage of 5 kV. For TEM measurement, the aqueous colloidal solution of AuNPs was dropped 
on the copper grid and dried under vacuum. The TEM images and EDX measurements were taken using TEM 
HD-2000 (Hitachi) with an accelerating voltage of 200 kV.  
UV-Vis-NIR spectroscopy was carried out with a V-670 spectrometer (JASCO, Japan) to examine the 
optical property of nanoparticles and SERS substrates. The extinction spectra of a colloidal solution of 
nanoparticles were obtained by using liquid cell holder module with a path length of 10 mm. The extinction 
spectra of SERS substrate (Au@Ag core-shell nanoparticle deposited on ITO substrates) were measured using 
 
Fig. 3-2 Schematic mechanism of carboxyl group activation by EDC/NHS.  
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a transmission module for the solid samples. The FTIR spectra of PEGylated-MBA-AuNPs, SERS probes, the 
reaction of the exchange capping molecule of SERS substrate from hydrophobic to hydrophilic were obtained 
with a FTIR spectrometer (Nicolet 4700) in an attenuated total reflection (ATR) geometry using a diamond 
prism.  
Raman spectra were measured with a micro-Raman spectrometer system with a He-Ne laser and a 
charge-coupled device (CCD) detector (NT-MDT NTEGRA Spectra or Lambda Vision MicroRAM-300). For 
the NT-MDT NTEGRA spectra system, the excitation laser light was focused on the sample surface using a 
40 objective lens with a numerical aperture of 0.65, and the Raman scattered light was collected by the same 
objective lens. The Raman scattered light was dispersed with a single spectrograph of a focal length of 520 nm 
with a grating of 1200 grooves/mm. For the MicroRAM-300 system, a 50× objective lens with a numerical 
aperture of 0.75 was used for the excitation and collection of Raman scattered light. A single spectrograph of 
a focal length of 300 nm with a grating of 600 grooves/mm was used to record Raman spectra. The photograph 
and optical pass of MicroRAM-300 are shown in Fig. 3-3. The laser spot size was estimated about to be 4 µm 
in diameter. For both Raman spectrometer systems, a 632.8 nm line of the He-Ne laser was used for excitation, 
and the laser power was set to 100 µW at the sample surface. Stokes Raman shift spectra were obtained with 
an exposure time of 50 s. To improve the signal-to-noise ratio, typically five to ten spectra were averaged. 
 
Fig. 3-3 Photograph (a) and sketch (b) of experimental set up for the MicroRAM-300 Raman spectrometer 
consisted of excitation laser (He-Ne laser), optical lens (50× with a numerical aperture of 0.75), mirrors, edge 
filter, confocal optical microscope, and detector (CCD).  
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3.4 Characterization methods  
3.4.1 Calibration  
Calibration curve is the standard curve for determining the concentration of target analytes in SERS 
immunosensor. The calibration curve is the plot of the measurable signals and concentration of analytes. Figure 
3-4 shows typical calibration curve. The linear calibration curve is obtained by the method of least squares. 
This fitting provides much information for the quantitative analysis, such as linearity, linear equation, limit of 
detection, and sensitivity. Linearity shows the accuracy of the measured response to a straight line, 
mathematically represented as y=mx+c, where c is the concentration of the analyte, y is the observed intensity, 
and m is the slope. The sensitivity of the sensor is the slope of the linear calibration curve. The sensitivity is 
defined as the smallest change in the concentration of an analyte that is required to bring a big change in the 
response of the output signal.  The lowest amount of analyte that can be detected by immunosensor defines its 
limit of detection (LOD) [74].  
In this study, the linear sensitivity curve and limit of detection (LOD) can be expressed by eq1 and 
eq2, respectively.   
Iob = ax + b,                                                        (1) 
where Iob is the observed Raman intensity, and x is the concentration of target bio-analytes. When  the mean 
value and the standard deviation of the Raman intensity for the control sample are denoted by I avecontrol and 
control, respectively and the standard deviation of the Raman intensity for the immunoassay at a target 
concentration near and higher than LOD is denoted by LOD, we defined the LOD by the following equation: 
LOD = xLOD =  
{Icontrol
ave +1.645(σcontrol+σLOD)−b}
a
.                  (2) 
 
Fig. 3-4 Typical calibration curve of immunosensor. 
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3.4.2 Selectivity 
Selectivity is the performance of a sensor to detect only a specific analyte in a complex samples [74]. Fig. 3-5 
shows the selectivity of the immunoassay against other proteins. Immunosensor must be able to detect only 
the target analyte in the complex matrix. The signal of the interference should be much lower than that of 
target analyte one.  
 
3.4.3 Reproducibility 
Reproducibility is the performance of immunosensor to generate similar signals for many replication [74]. The 
reproducibility is characterized by the precision and accuracy of the transducer and electronics in an 
immunosensor. Fig. 3-6 shows the high reproducibility of the immunosensor. The precision of reproducibility 
of the sensor is usually characterized in terms of the relative standard deviation (%RSD) of the replications. 
The %RSD, which is often expressed as a percentage, is calculated by %RSD = SD/ x̄, where SD is the sample 
standard deviation, and x̄ is the mean value of the sample data. The acceptable %RSD value for the 
immunosensors is less than 30% of the variation within the sample replications [75].  
 
Fig. 3-5 Typical selectivity of the immunosensor. The strong intensity was detected from target analyte while 
the intensities of other antigens (negative results) are weak.  
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Fig. 3-6 Typical reproducibility of immunosensor. The highlighted area represents the probability of 
data variation with acceptable value.  
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CHAPTER IV 
DEMONSTRATION OF SURFACE-ENHANCED RAMAN SCATTERING (SERS) 
IMMUNOASSAY FOR DETECTION OF INFLUENZA A VIRUS 
 
The study of influenza A detection has attracted attention because it is a severe pandemic all over the 
world. Influenza carries a high mortality particularly in the young people (3-12 years old) [76]. Rapid and high 
sensitive influenza virus detection are important in terms of disease diagnosis, and point of care testing. In this 
chapter, an extrinsic SERS-based immunosensor for detecting nucleoprotein, influenza A antigen, and its 
performance were reported. In this sensor, the immunoreaction occurs on two-dimensional (2D) arrays of gold 
core@silver shell (Au@Ag) nanoparticles (NPs) on an ITO substrate, served as a SERS substrate to improve 
the sensitivity.  The SERS probes were fabricated by decorating PEGylated, 4,4’-thiobisbenzenethiol (TBBT)-
labeled gold nanoparticles (AuNPs) with antibodies specific to the target nucleoprotein. TBBT was chosen as 
a Raman reporter molecule in this SERS immunoassay because of its outstanding characteristic Raman spectra. 
The 4 times sensitivity enhancement was achieved by replacing a flat Au film with a 2D array of Au@Ag 
NPs, whose localized surface plasmon resonance (LSPR) was tuned to the excitation laser wavelength of 633 
nm.  Finally, we demonstrated the applicability of our SERS immunoassay system to complex biological 
samples using a stock solution of Pandemic 2009 influenza A H1N1 virus-infected allantoic fluid containing 
5.6×103 TCID50/mL (50% tissue culture infectious dose). 
First of all, the information and structure of influenza A virus are described. Then, the SERS probe 
synthesis, the immunosubstrate preparation, and the immunoassay protocol are explained. Next, the SERS 
probe and hydrophilic SERS substrate characterization, the optimization of immunoassay process, the 
performance of SERS immunosensing system (sensitivity, selectivity, and reproducibility), and analysis of the 
nucleoprotein in the infected allantoic fluid were reported. Finally, the conclusion of this topic was presented.  
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4.1 Influenza A  
 Influenza A is one of influenza virus types and can infect many kinds of hosts, e.g. bird, pig, horse, sheep, 
and human. This virus can be transmitted from one host to other hosts and may cause a severe pandemic. 
Influenza A virus contains 11 or 12 viral proteins, including nonstructural protein1 (NS1), matrix protein (M1), 
ion channel (M2), hemagglutinin (HA), neuraminidase (NA), nucleoprotein (NP), components of the RNA-
dependent RNA polymerase complex (PB1, PB2, and PA), N40 protein, and pro-apoptotic protein (PB1-F2) 
(See Fig. 4-1) [77]. Influenza A virus has several subtypes, which are categorized by two proteins on the virus 
envelope: Hemagglutinin and neuraminidase. There are 18 different hemagglutinin subtypes (H1 to H18) and 
11 different neuraminidase subtypes (N1 to N 11).  In particular, three influenza subtypes (H1N1, H2N2, and 
H3N2) can be circulated among human.  
 The last pandemic, in 2009, influenza (H1N1 swine flu) outbreaks firstly happened in the United States 
and spread quickly across the world. The estimated number of infected people was about 43 to 89 million 
people. This influenza A virus has been recorded as one of the world’s most dangerous pathogens because of 
its high viability and easy spread [78].   
 The traditional diagnostic methods for influenza A virus detection are based on the virus isolation 
from tissue cultures, or embryonated chicken eggs [79]. To obtain the effective and reliable result from these 
methods, several days for experiment and long analysis time are required. There are ELISA (Enzyme-linked 
immunosorbent assay) methods for detecting viral proteins relying on the interaction between antibody and 
virus antigens. This method requires many steps of reaction with long analysis time. However, the sensitivity 
is quite low. To obtain high sensitivity and specificity with shorter analysis time (a few hour), the molecular 
methods based on polymerase chain reaction (PCR), reverse transcriptase polymerase chain reaction (RT-
PCR), and real-time PCR are adopted. The shortcoming of these methods is the sample preparation (isolation 
of genetic material from the virus without any contamination is required). 
 Nowadays, the commercial test ELISA-based kits of QuickVue Influenza A+B Test (Quidel, San 
Diego, CA, USA) for influenza detection are available by employing the reaction between antibody and 
nucleoprotein (is one of the most conserved and abundant structural proteins inside the virion). The structure 
and the binding site of nucleoprotein against monoclonal antibody are shown in Fig. 4-1 [80]. These kits are 
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capable of identifying influenza A H1N1 in the respiratory samples [81]. However, it should be noted that 
these kits are more suitable for Influenza A detection of the young patients than aged. Therefore, the 
improvement of a detection method for monitoring and observing the patient’s condition with short analysis 
time is still demanded. The method bases on the multidisciplinary study of physics, chemistry, and biology 
may offer the good way to improve the detection performance.  
   
4.2 Experimental 
4.2.1 SERS probe preparation  
SERS probes were prepared in three steps: synthesis of 25 nm citrate-capped AuNPs, modification of 
AuNPs with TBBT (Raman reporter) and PEG molecules, and antibody immobilization. TBBT was chosen as 
a Raman reporter molecule because it shows strong and outstanding Raman bands at 1077 and 1572 cm-1 
[82,83]. First, AuNPs were obtained by reducing HAuCl4 with sodium citrate. In brief, 95 mL of an aqueous 
solution containing 5 mg of HAuCl4 was refluxed. Then, 5 mL of 1 % (w/v) aqueous solution of sodium citrate 
 
Fig. 4-1 Structure of influenza A virus. Influenza A virus has a lipid bilayer envelope, in which there are 8 
proteins (PB2, PB1, PA, HA, NP, NA, M, NS). The outer layer of lipid envelope is coated with HA, NA, 
M1, and N2. The zoomed view is the structure of trimer nucleoprotein. The yellow, red, blue, and green 
regions represent the location of amino acid residues involved in the interaction with monoclonal antibody.  
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was added to the boiling solution.  The reflux was continued for 30 min [84]. An average diameter of obtained 
AuNPs was 26 ± 2 nm, which was determined from the SEM image (Fig. 4-2). Following the nanoparticle 
synthesis, AuNPs were simultaneously labeled with TBBT and thiolated PEG acid (COOH-PEG-SH) to avoid 
the particle aggregation and precipitation. A mixed solution of 5 µM ethanolic solution of TBBT (1.5 mL) and 
1 µM aqueous solution of COOH-PEG-SH (1.5 mL) were freshly prepared and added to the colloidal solution 
of 25 nm citrate-capped AuNPs (9 mL). After 30 min incubation, 65 µL of a 1.5 mM aqueous solution of 
thiolated PEG (PEG-SH) was added to the colloidal solution, and then further incubation was performed for 2 
h to acquire long-term stability of particles. To wash Au particles, centrifugation was conducted at 10,000 rpm 
for 10 min, and then the supernatant containing excess TBBT, COOH-PEG-SH, and PEG-SH molecules was 
removed. Then, the remaining AuNP suspension was re-dispersed in water. This washing process was repeated 
twice for removal of unbound molecules. This colloidal solution can be stored at 4C for more than 6 months.  
In the last step, influenza A antibodies were covalently immobilized on the TBBT-labeled AuNPs.  
Briefly, we firstly adjusted the concentration of the aqueous solution of TBBT-labeled AuNPs so that its optical 
density becomes unity at 532 nm (= absorption peak wavelength).  Then, 0.5 mL of the TBBT-labeled AuNPs 
solution and 100 µL of an aqueous solution including 0.2 mg of EDC and 0.2 mg of NHS were mixed and kept 
at room temperature for 30 min to complete activation of carboxyl groups of COOH-PEG-SH molecules on 
AuNPs.  Then, the excess amount of EDC/NHS was removed by three cycles of centrifugation (10,000 rpm, 
10 min) and re-dispersion in water. In the last re-dispersion process, the particles were re-dispersed in 10 mM 
PBS solution (pH 7.4). Finally, 3 µL of a 5.3 mg/mL of Influenza A antibody was added to the colloidal 
solution and incubated for 3 h at room temperature. The particles were washed by two cycles of centrifugation 
at 10,000 rpm for 10 min and re-dispersion in PBS solution.  These particles are called “SERS probes”. The 
schematic processing of SERS probe (Ab-TBBT-PEGylated-AuNPs) synthesis was shown in Fig. 4-3.   
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4.2.2 SERS immunoassay protocol for Influenza A 
The SERS immunosensor fabricated in this research is based on a direct immunoassay (Fig. 4-4). After 
freshly prepared hydrophilic SERS substrate was performed by immersing annealed as-prepared SERS 
substrate into MHDA solution,  this substrate (10  10 mm2) was divided into quarters. A 5  5 mm2 
hydrophilic SERS substrate was used as the solid support for immunoassay. First, the freshly prepared 
hydrophilic SERS substrate was activated by successively dropping 10 µL of a 15 mM EDC aqueous solution 
and 10 µL of a 15 mM NHS solution. The mixed droplet was kept on the substrate for 30 min. Then, the 
substrate was washed with distilled water three times and dried by nitrogen gas. Next, 1 µL of a recombinant 
nucleoprotein solution with different concentrations was directly dropped onto the SERS substrate and 
incubated for 30 min for immobilizing recombinant nucleoprotein. The incubation time was optimized (see 
Section 3.3.1). After that, the SERS substrate was washed for 5 min each in 10 mM PBS solution followed by 
DI water under stirring condition. Subsequently, 5 µL of a SERS probe aqueous solution (optical density = 
0.5) was dropped onto the substrate to react with the target nucleoprotein. The incubation time for 
 
Fig. 4-3 Schematic illustration of SERS probe synthesis (Ab-TBBT-AuNPs). 
 
  
Fig. 4-2 SEM image of 25nm-citrated AuNPs drop-casted on a Si wafer substrate. The 
histograms of size distribution of each particles are showed at the right hand side of SEM 
images. 
40 
 
immobilizing SERS probes on recombinant nucleoproteins was 1 h, which was also optimized. Finally, the 
substrate was washed twice in stirred PBS solution for 5 min and then twice in stirred water for 5 min.  
 
4.3 Results and discussion 
4.3.1 Characterization of SERS probes 
As mentioned above, the SERS probes for Influenza A nucleoprotein detection were prepared in three steps; 
(i) synthesis of 25 nm citrate-capped AuNPs, (ii) modification of AuNPs with TBBT  (Raman reporter) and 
PEG molecules, and (iii) immobilization of influenza A antibody. The high uniformity of citrate-capped 
AuNPs in shape (spherical) and in size (average diameter of 26 ± 2 nm) was confirmed by SEM (Fig. 4-2). 
The extinction spectra of colloidal solutions of citrate-capped AuNPs, TBBT-PEGylated AuNPs, and SERS 
probes show a single narrow LSPR peak at around 523 nm (see Fig. 4-5). The peak position was red-shifted 
by a few nanometers by PEGylation, similar to the reports by X. Qian and M. Xiao groups [85,86]. This red-
shift can be explained by a change in the local dielectric constant surrounding AuNPs. No spectral change of 
the LSPR was observed by antibody decoration on PEGylated AuNPs. The single LSPR peak with a narrow 
width was observed for the AuNP solutions in all three steps, indicating that the TBBT-PEGylated AuNPs and 
SERS probes are well dispersed and no aggregation occurs even after labeling AuNPs with TBBT.  
 
Fig. 4-4 Schematic illustration of direct immunoassay on 2D Au@Ag NP array substrate. rt: room 
temperature. 
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Figure 4-6 shows the Raman spectra of solid TBBT, TBBT-PEGylated AuNPs, and SERS probes. The 
characteristic Raman bands of solid TBBT were observed at 1077 and 1572 cm-1, which are assigned to the 
vibrations of C-S and CC(ring), respectively.[82,83] The corresponding bands were observed at 1065 and 1565 
cm-1 for TBBT-PEGylated AuNPs and SERS probes [87]. These vibrational frequency shifts were reported for 
TBBT adsorbed on AuNPs, and AgNPs, indicating chemisorptions of TBBT. The C-S-H band of solid TBBT 
at 917 cm-1 completely disappears on the TBBT-PEGylated AuNPs and SERS probes, indicating that TBBT 
molecules are chemisorbed on the colloidal AuNP surface by losing two H atoms of S-H bonds. Based on 
TBBT molecular structure, there are two possible double-end adsorption structures; one is bidentate adsorption 
on a single AuNP, and the other is bridging adsorption between adjacent AuNPs, which leads to aggregation 
of AuNPs. After conjugation of influenza A antibody, the characteristic peaks of TBBT were still dominant; 
hence, both peaks at 1065 and 1565 cm-1 can be used to detect the completion of specific antigen-antibody 
recognition. Since the background signal originating from the SERS substrate is more structureless around the 
1565 cm-1 band than that around the1065 cm-1 band, in this study the 1565 cm-1 band was used for detection 
of the nucleoprotein of influenza A virus. 
 
 
Fig. 4-5 Extinction spectra of colloidal solutions of citrated AuNPs, PEGylated AuNPs labeled with 
TBBT, and SERS probes. 
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4.3.2 Characterization of hydrophilic SERS substrate  
Before SERS substrate fabrication, the particle size, size distribution, and morphology of Au@Ag core-shell 
NPs, which were the constituent NPs of the SERS-active substrates, were characterized using SEM, TEM, and 
EDX. The shape of Au@Ag NPs was nearly sphere as shown in Fig. 4-7(a). The size distribution (51 ± 4 nm) 
evaluated from 250 particles in SEM images was shown in Fig. 4-7(b). The core-shell structure of Au@Ag 
NPs was confirmed by EDX measurement. It was proved that Ag shell was grown uniformly on the Au core 
as seen in Fig. 4-7(c). The Ag shell thickness (4.5 nm) was estimated from the difference in average particle 
size between the Au core particles (42 ± 4 nm) and the final Au@Ag NPs (51 ± 4 nm). 
 
 
Fig. 4-7 (a) SEM image and (b) size distribution of Au@Ag NPs used in this study. (c) EDX 
mapping of an Au(42 nm)@ Ag(4.5 nm) NP. 
 
Fig. 4-6 Raman spectra of solid TBBT, TBBT-PEGylated AuNPs, and SERS probe.  
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Figure 4-8(a) shows high (100k) and low (25k) magnification SEM images of a 2D array prepared by 
the hybrid method, indicating the high uniformity and surface coverage of the 2D array. The solid curve of 
Fig. 4-8(c) shows the extinction spectrum of the as-prepared 2D array. The extinction peak assigned to LSPR 
of the 2D array is observed around 627 nm. This result shows successful tuning of LSPR energy to the 
excitation (633 nm) of our Raman measurement. Hence, the highest enhancement effect is expected from the 
2D array SERS substrate.  
Since the constituent Au@Ag NPs of the as-prepared 2D array are stabilized with mixed alkanethiol 
molecules, this substrate surface is hydrophobic. As shown in the inset of Fig. 4-8(a), the contact angle of a 1 
L water droplet was 130, indicating a strong water-repellent characteristic. Thus, the 2D array must be 
hydrophilized before utilizing it as a substrate in an immunoassay using aqueous solutions. The 
hydrophilization was performed by annealing the hydrophobic 2D array at 90C for 1 h and then immersing it 
in an ethanolic solution of MHDA at 50 C for 12 h. Fig. 4-8(b) shows SEM images of the MHDA-
functionalized 2D array and contact angle of a water droplet.  The MHDA-functionalization significantly 
reduced the water contact angle from 130 to 35, indicating successful hydrophilization. The arrangement of 
Au@Ag NPs was not influenced by MHDA-functionalization as confirmed by the SEM images. In addition, 
the extinction spectrum shown by the dashed curve in Fig. 4-8(c) can be used to confirm that optical property 
of the SERS substrate remains unchanged.  
 
  
Fig. 4-8 25k and 100k magnification SEM images of (a) as-prepared 2D array and (b) MHDA-
functionalized 2D array.  The insets of (a) and (b) show the contact angle of a 1 l water droplet on 
each substrate surface.  (c) Extinction spectra of as-prepared (solid curve) and MHDA-functionalized 
(dashed curve) 2D array. 
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This hydrophilization was also confirmed by attenuated total reflection Fourier transform infrared (ATR-
FTIR) spectroscopy (Nicolet 4700). All reaction was confirmed by infrared (IR) absorption spectra taken at 
each step. Fig. 4-9(a) is the IR spectrum of the hydrophobic 2D array.  Four absorption bands were clearly 
observed in (C-H) region. The absorption bands at 2847 and 2913 cm-1 are assigned to the methylene 
symmetric and asymmetric C-H stretching vibrations, respectively.  The  2883 and  2960 cm-1 bands are 
assigned to the methyl symmetric and asymmetric C-H stretching vibrations, respectively [88].  Since the 
alkanethiols (dodecanethiol and octadecanethiol) have both a methyl end group and a methylene chain, the 
appearance of the four bands shows that the Au@Ag NPs are capped with alkanethiols. The FTIR spectrum 
of the annealed hydrophobic 2D array is shown in Fig. 4-9(b). The absorption intensity of the four bands was 
decreased by annealing, indicating that the alkanethiol capping molecules were partly desorbed from the 
Au@Ag NPs. After the MHDA treatment, an absorption band assigned to the carboxyl C=O stretching 
vibration was observed around 1710 cm-1, and the 2883 and  2960 cm-1 bands assigned to the methyl C-H 
stretching vibrations disappeared as shown in Fig. 4-9(c). Since MHDA has a carboxyl end group but has no 
methyl end group, this spectral change shows that the alkanethiol capping molecules were replaced with 
MHDA. Since the LSPR wavelength of the resultant hydrophilic SERS substrate is matched with the Raman 
excitation wavelength (633 nm), this 2D array SERS substrate is suitable for an immunoassay.  
 
 
Fig. 4-9 ATR-FTIR spectra of the 2D array of Au@Ag NPs: (a) as-prepared hydrophobic 2D array, 
(b) after annealing at 90C for 1 h, and (c) after MHDA treatment.  
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4.3.3 SERS Immunoassay 
4.3.3.1 Optimization of immunoassay process 
 To maximize the performance of our immunoassay system and shorten the process time simultaneously, the 
incubation time for immobilizing recombinant nucleoprotein and SERS probes was optimized. To find the 
optimal incubation time of recombinant nucleoprotein, the whole immunoassay was performed with a different 
time for incubating the recombinant nucleoprotein. In this experiment, the concentration of nucleoprotein was 
fixed at 1.34 µg/mL, its incubation time was varied from 15 min to 3 h, and the SERS probes were incubated 
for 3 h. The Raman spectra for a different incubation time of recombinant nucleoprotein are shown in Fig. 3-
10(a). The intensity of the characteristic band of TBBT at 1565 cm-1 was plotted in Fig. 4-10(b) as a function 
of the incubation time. The peak intensity increased with increasing incubation time and then saturated around 
30 min. For incubation time of more than 2 h, the decrease of the peak intensity was observed. The reduction 
of peak intensity could be due to the denaturation of protein structure from the active form to an inactive form 
over time. Such denatured nucleoprotein lost the biological activity for binding to antibodies, leading to the 
lowering of the binding coefficient of nucleoprotein-antibody. From these results, the incubation time for 
immobilizing the recombinant nucleoproteins was determined to be 30 min.  
Next, the incubation time of the SERS probes was optimized. Fig. 4-11(a) shows the Raman spectra 
of the immunoassay performed with a different incubation time of SERS probes, under a fixed immobilization 
condition of the recombinant nucleoprotein: 1.34 µg/mL and 30 min. The characteristic peak intensity related 
to an incubation time of SERS probes is shown in Fig. 4-11(b). These results suggest that the incubation time 
of 1 h is required for sufficient nucleoprotein-antibody recognition reaction. For incubation time longer than 
1 h, ~40% decrease in intensity was observed. It could be also due to the denaturation of protein structure 
induced by a long incubation of SERS probes. Thus, the suitable incubation time for SERS probes is 1 h.   
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4.3.3.2 Performance of SERS immunosensing system  
In order to clarify the effect of the 2D array SERS substrate towards the sensitivity improvement, a 40 nm-
Au/10 nm-Cr film on a quartz substrate was used as a comparison. This film was prepared by depositing Cr 
 
Fig. 4-10 (a) Raman spectra when the immunoassay was performed with different incubation time of 
recombinant nucleoprotein, and (b) Relationship between the peak intensity of the 1565 cm-1 band of TBBT 
and the incubation time of recombinant nucleoprotein. The dashed curve is a guide for the eye. 
 
Fig. 4-11 (a) Raman spectra of the immunoassay performed with different incubation time of SERS probes 
under a fixed immobilization condition of the recombinant nucleoprotein (1.34 µg/mL and 30 min), and (b) 
peak intensity of the 1565 cm-1 band of TBBT corresponding to incubation time of SERS probes. The dashed 
curve is a guide for the eye. 
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and Au sequentially on the quartz substrate by thermal evaporation in a vacuum (<10-4 Pa). The Au film surface 
was hydrophilized by immersion in an ethanolic solution of MHDA for 12 h at 50 C, and then activated by 
EDC/NHS in the same manner as the SERS substrate.  For sensitivity study, the recombinant nucleoprotein 
solutions with different concentrations were prepared via serial dilution of a 134 µg/mL stock solution of 
recombinant nucleoprotein to final concentrations of 134, 67, 13.4, 6.7, 1.34, 0.67, 0.134, 0.067, 0.0134, and 
0.0067 µg/mL, and the whole immunoassay was conducted.  
Fig. 4-12(a) shows the Raman spectra of the immunoassay conducted on the SERS substrates.  For the 
control, PBS solution without recombinant nucleoprotein was dropped onto the substrates. The result 
demonstrated that several Raman bands were observed for the control sample on a SERS substrate in the range 
of 600 to 1600 cm-1, which can be tentatively assigned to the vibrational modes of MPTMS and activated 
MHDA. The assignment was presented in Table 4-1. These bands are found to be well separated from the 
characteristic Raman bands of TBBT at 1565 cm-1. As expected, the 1565 cm-1 band was negligibly weak for 
the control samples, and its intensities increased with increasing concentration of recombinant nucleoprotein.  
Fig. 4-12(b) show the sensitivity curves of the immunoassay conducted on the SERS substrate and the 
Au film substrate in the entire measurement range. The sensitivity curves were obtained by plotting the 
intensity of the 1565 cm-1 band as a function of the concentration of recombinant nucleoprotein. The stronger 
Raman signal was observed for the SERS substrate than that of the Au film substrate with the same 
concentration of the target. Both sensitivity curves show a similar pattern of dependence; i.e. initially the 
Raman intensity increases almost linearly with increasing concentration of recombinant nucleoprotein, and 
then the increasing rate gradually decreases. The linear relation was observed in the concentration range of 
0.0067 to 0.134 µg/mL for both substrates.  
The linear sensitivity curves are shown in Fig. 4-12(c). Comparing the slopes, we found that the 
sensitivity of immunoassay improved about 4 times by using the 2D Au@Ag NP array substrate, instead of 
the flat Au film substrate. The limit of detection (LOD) of the immunoassay was estimated using the linear 
sensitivity curves. The definition of LOD used in this study is described in experimental section. The LOD of 
the immunoassay using the SERS substrate was 8 ng/mL (0.14 nM), while that using the Au film substrate 
was 59 ng/mL (1.05 nM).  Since the increase of the surface area of the 2D-NP array against the flat surface is 
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at the outside twice, the improvement in the sensitivity and detection limit can be mainly attributed to plasmon 
coupling between the SERS probe and the SERS substrate. Finally, comparison of the LOD with those of other 
techniques previously reported for detecting the same analyte. The LOD of our SERS immunoassay system (8 
ng/mL) is much lower than those of fluorescence-based LFIA (250 ng/mL), [89] an immune-interferometric 
sensor (1µg/mL), [90] and comparable to that of the electrochemical immunoassay (e-ELISA) (10 ng/mL). 
[91] 
Table 4-1 Possible peak assignment of the Raman spectrum of the EDC/NHS-activation 2D array.  
Observed peak (cm-1) Possible assignment 
679 (Si-C)  [92] 
702 sh (S-C)T  [92,93] 
750 CH2 rock [93,94] 
837 CH wagging [95] 
850 CH2 rock [94] 
952 (Si-OH) [92] 
1002 (C-C)T [92,94] 
1036 CH2 rock [92,94] 
1104 (Si-O-Si) [92] or (C-C)T  [93] 
1138 CH2 twist [92] or (C-C)T  [93] 
1156 C-O stretch  [95] 
1195 CH2 twist [92,94] 
1217 CH2 twist [92] or wagging [94] 
1272 CH2 twist [92] or wagging [94] 
1303 CH2 twist [92,94] 
1338 CH2 twist [92] or wagging [94] 
1455 CH2 bending [94-96] 
sh: shoulder, : stretching, T: trans.  
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4.3.3.3 Selectivity 
To examine the selectivity of our immunoassay system, a variety of proteins; recombinant nucleoprotein, 
avidin, bovine serum albumin (BSA), lysozyme, tryptone, and amicase, were immobilized on the SERS 
substrates at the same concentration (13.4 µg/mL). The Raman signal intensity observed after incubating SERS 
probes are summarized in Fig. 4-13. The intense characteristic peak of TBBT at 1565 cm-1 was observed only 
  
 
Fig. 4-12 (a) Raman spectra of the immunoassay performed on the SERS substrates. The concentration 
of nucleoprotein was: 0 (control), 0.0067, 0.0134, 0.067, and 0.134 µg/mL from the bottom to the top. 
(b) Sensitivity curves of the immunoassay performed on the SERS and Au substrates over the entire 
measurement range from 0.0067 to 134 ug/mL of nucleoprotein concentration. These sensitivity curves 
were obtained from the peak intensity of the1565 cm-1 band. The solid and dashed curves are guides for 
the eye. (c) Sensitivity curves in the linear region. The solid and dashed straight lines are obtained by 
the method of least squares. The solid and open symbols in (b,c) shows the data points for the 
immunoassay performed on the SERS and Au substrates, respectively. 
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for recombinant nucleoprotein.  The signal intensity for the others protein is comparable to that of the negative 
control sample (PBS solution without nucleoprotein). This result clearly shows that our SERS immunoassay 
has high selectivity against recombinant nucleoprotein.  
 
4.3.3.4 Reproducibility 
Reproducibility of our SERS immunoassay was examined by performing the immunoassay using ten different 
SERS substrates. In this measurement, the concentration of recombinant nucleoprotein was fixed at 1.34 
µg/mL. Ten repetitive measurements were performed at different positions for each sample. The relative 
standard deviation (RSD) of the peak intensity of the 1565 cm-1 band within the sample was less than 5 %. The 
sample-to-sample variation of detected Raman intensity was shown in Fig. 4-14. The variation of the average 
intensity was calculated to be 4.6 % RSD, which were considered acceptable values (<30%RSD) [75]. The 
small sample-to-sample variation was attributed to the high uniformity and high reproducibility of surface 
coverage of 2D array. From the results, we can confirm that our SERS immunoassay possesses high 
reproducibility.  
 
 
Fig. 4-13 Selectivity of SERS immunoassay. The concentration of all proteins were fixed at 13.4µg/mL. 
The peak intensity of the 1565 cm-1 band was plotted. 
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4.3.3.5 Analysis of the nucleoprotein in infected allantoic fluid 
To demonstrate the applicability of our SERS immunoassay system for complex biological samples detection, 
a stock solution of Pandemic 2009 influenza A H1N1 virus-infected allantoic fluid containing 5.6×103 
TCID50/mL (50% tissue culture infectious dose) was used. The infected allantoic fluid solutions with different 
concentrations were prepared by serial dilution of the stock solution with extraction buffer solution.  1 L of 
diluted allantoic fluid was dropped directly on the SERS substrate and incubated at 4C for 30 min,[89] and 
then the substrate was rinsed with PBS solution and distilled water.  Before Raman measurement, a SERS 
probe solution was dropped on the substrate and incubated for 1h, and subsequently, the substrate was rinsed 
with distilled water. Fig. 4-15(a) and 4-15(b) show the Raman spectra and the sensitivity curve, respectively, 
of our immunoassay system with respect to the infected allantoic fluid. Initially, the intensities of the 
characteristic Raman peaks of TBBT are increased with increasing concentration of the allantoic fluid, and 
then the increasing rate gradually decreases.  The linear relation was observed in the range of 5 to 56 
TCID50/mL for a characteristic peak at 1565 cm-1 with a correlation coefficient (R2) of 0.96. The detection 
limit was estimated to be 6 TCID50/mL. This result indicates that this SERS immunoassay has a great 
performance to detect nucleoprotein from an allantoic fluid containing various kinds of interference matrix. 
This highly sensitive detection of influenza A nucleoprotein in a complex matrix is strongly attributed to the 
 
Fig. 4-14 Reproducibility of SERS immunoassay (peak intensity of the 1565 cm-1 band). The 
concentration of recombinant nucleoprotein was fixed at 1.34 µg/mL. 
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high sensitivity and selectivity of our SERS immunoassay system. The performance of other representative 
techniques for detecting infected allantoic fluid of Influenza A is summarized in Table 4-2. The LOD of our 
SERS immunoassay system (6 TCID50/mL) is lower than those of the previously reported techniques: 
Fluorescence based-Lateral flow immunoassay (11 TCID50/mL),[89] Colorimetric based Lateral flow 
immunoassay (47 TCID50/mL for Influenza A nucleoprotein, [97] and 5  102 TCID50/mL for Influenza A 
virus).[98]  
 
Table 4-2 Summary of LOD of representative sensors for detecting infected allantoic fluid. 
 
 
 
 
 
 
 
 
 
 
Probe Biomarker 
Type of 
assay 
Detection 
method 
Linear range LOD ref 
Cy5- doped 
SiO2NPs 
infected 
allantoic 
fluid 
sandwich 
Fluorescence 
based-ELISA 
50-1000 
TCID50/mL 
11 TCID50/mL 
     
[89]       
Dual mAb-
immunogold 
infected 
allantoic 
fluid 
sandwich 
Color based 
Lateral flow 
immunoassay 
NA 47 TCID50/mL [97] 
mAb-
immunogold 
infected 
allantoic 
fluid 
sandwich 
Absorbance-
based LFIA 
biosensor 
NA 
5102 
TCID50/mL 
[98] 
PEGylated, 
TBBT-
labeled 
immunogold 
infected 
allantoic 
fluid 
direct 
SERS-based 
biosensor 
5-56  
TCID50/mL 
6 TCID50/mL 
This 
work 
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4.4 Conclusion  
A SERS immunoassay with high sensitivity and selectivity for Influenza A was demonstrated utilizing both 
PEGylated TBBT-labeled AuNPs covered with influenza A antibody as the SERS probes and hydrophilic 
Au@Ag 2D array as the SERS substrates. The antibody-antigen recognition was detected by observing 
characteristic Raman signal of TBBT (Raman reporter). Immunoassay taken place on SERS substrates has 
about 4 times higher sensitivity than immunoassay on Au film substrates because the Raman signal from the 
SERS probes is amplified by the electromagnetic field enhancement effect of the SERS substrate. This 
immunoassay shows the good performance to detect the target nucleoprotein in a complex biological matrix 
that contains various kinds of interferences with the detection limit of 6 TCID50/mL. These results indicate that 
using a well-tuned Au@Ag 2D array as a SERS substrate is an effective way for improving the sensitivity of 
SERS-based biosensors. 
 
 
Fig. 4-15 (a) Raman spectra of the immunoassay for infected allantoic fluid, whose concentration was 
varied from 0 (control) to 56 TCID50/mL. (b) Sensitivity curve of the SERS immunoassay for influenza 
A infected allantoic fluid. This sensitivity curve was obtained by plotting the peak intensity of the 1565 
cm-1 band. The data points over the entire measurement range are shown in the inset. The dashed 
straight line was obtained by the method of least squares.   
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CHAPTER V 
INVESTIGATION OF THE FACTORS DETERMINING SENSITIVITY OF SERS 
IMMUNOASSAY: SERS PROBE SIZE AND SEPARATION DISTANCE BETWEEN SERS PROBE 
AND SUBSTRATE  
 
The sensitivity of the sensor relies on the amplification of the signal from SERS probe after antigen-
antibody recognition, which depends on the localized surface plasmon resonance (LSPR) of AuNPs of SERS 
probe and the strength of electromagnetic field enhancement between probe and substrate. The LSPR of 
AuNPs depends on their size, shape, and material [99-101]. Compared with other parameters, optimizing the 
AuNPs size of probes is a simple and effective ways to improve the detection sensitivity. Moreover, the 
sensitivity of immunoassay influences by the plasmon coupling between the SERS probe and SERS-active 
substrate, whose strength becomes strong as the separation distance between the SERS probe and substrate 
decreases. In sandwich SERS immunoassay, the capture antibody-antigen-detection antibody acts as the 
separation barrier between the SERS probe and substrate. In addition to the size of the antigen/antibody, the 
size of MNP of the SERS probe also influences the plasmon coupling between the SERS probe and SERS-
active substrate, because the strong electromagnetic field associated with the LSPR of MNPs decays with a 
length scale of the size of MNP [102,81]. This means that the larger MNP allows larger separation distance 
between the SERS probe and SERS-active substrate. Therefore, from the viewpoint of the plasmon coupling, 
the optimization of the MNP size, and the size of antigen/antibody used in the immunoassay are important for 
realizing the high sensitive SERS-based immunoassay. 
In this chapter, the influence of the SERS probe size and the length of the antibody-antigen-antibody 
complex on the sensitivity of sandwich-type SERS-based immunosensors was investigated, in which 
hydrophilic 2D arrays of Au (42 nm-core)@Ag (5 nm-shell) NPs were used as the SERS-active substrates. 
The SERS probes are AuNPs functionalized sequentially with 4-mercaptobenzoic acid (MBA), 
heterobifunctional polyethylene glycol (HS-PEG-COOH), and the antibody specific to a target antigen. MBA 
was selected as the Raman reporter molecule because it shows strong Raman bands at 1089 and 1587 cm-1 and 
has a carboxyl group to immobilize an antibody. First, to find the optimal SERS probe size, sandwich 
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immunoassay for Human-IgG was performed using SERS probes of different Au-core sizes from 26 to 110 
nm. The highest SERS intensity (sensitivity) was observed at an Au-core size of 53 nm. Next, to examine the 
influence of the size of the immunocomplexes (capture antibody-antigen-detection antibody) on the sensitivity, 
the sandwich immunoassay for Human-IgG and prostate-specific antigen (PSA) was performed using SERS 
probes whose Au core size is 53 nm. Human-IgG and PSA were selected as representative large (36 nm) and 
small (28 nm) immunocomplexes, respectively. The sensitivity enhancement achieved by using the SERS-
active substrate instead of a flat Au substrate was evaluated for both immunoassays for Human-IgG and PSA. 
By comparing the sensitivity enhancement factors, we found that the sensitivity of the sandwich-type SERS 
immunoassay increases by a factor of 3 as the size of the immunocomplexes decreases from 36 nm to 28 nm. 
This result suggests that the sensitivity of SERS-based immunoassay performed on SERS-active substrates 
can be improved by adopting a smaller antibody or antibody-fragment for a given target antigen. Our SERS-
based immunoassay system showed a low detection limit of 0.3 pg/mL for free PSA and 0.05 pg/mL for 
Human-IgG. 
This chapter is organized into four sections. Firstly, the information of the two biological systems with 
different antigen sizes: immunoglobulin G (IgG) and prostate-specific antigen (PSA) are explained. Then, 
SERS probe synthesis and immunoassay protocols for H-IgG and PSA are described. The SERS probe 
characterization, the influence of the SERS probe size on the sensitivity of immunoassay, and the influence of 
the size of antigen/antibody complexes on the sensitivity of immunoassay are presented. Finally, the 
conclusion of this topic was reported. 
 
5.1 Biological systems in this study   
In this study, the two biological systems were selected in the SERS immunoassay as representative models of 
large and small antigen sizes: Immunoglobulin G (IgG) and prostate specific antigen (PSA).   
 5.1.1 Immunoglobulin G (IgG) 
IgG is the antibody produced by the immune system to fight with bacteria, viruses, and toxins. Immunoglobulin 
G (IgG) is the major class of the five classes of Ig in human beings: IgG, IgM, IgA, IgE, and IgD [103]. IgG 
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molecules are able to react with Fc receptors located on the surface of macrophage and natural killer cells. 
IgG is produced in a delayed response after infected by pathogens or allergens and can be circulated in the 
body for a long time. The long half-life of IgG in serum is useful for passive immunization by transfer of this 
antibody. The detection of IgG is performed to indicate a prior infection or vaccination. IgG can be divided 
into four subclasses: IgG1, IgG2, IgG3, and IgG4. Each IgG subclass has different structures and responds to 
different target antigens. The structures and properties of each IgG subclass are presented in table 5-1.  
Table 5-1 Structures and properties of IgG subclasses [103].  
Properties IgG1 IgG2 IgG3 IgG4 
General  
Structure 
 
 
Molecular mass (kDa) 
Amino acid in hinge area 
Inter-heavy chain disulfide bonds 
Mean adult serum level (g/l) 
Relative abundance (%) 
Half-life (days) 
Antibody response to: 
Protein 
Polysaccharides 
Allergens 
 
 
 
 
146 
15 
2 
6.98 
60 
21 
 
++ 
+ 
+ 
 
 
 
 
146 
12 
4 
3.8 
32 
21 
 
+/- 
+++ 
(-) 
 
 
 
 
170 
62 
11 
0.51 
4 
7-21 
 
++ 
+/- 
(-) 
 
 
 
 
146 
12 
2 
0.56 
4 
21 
 
++ 
+/- 
++ 
 
5.1.2 Prostate-specific antigen (PSA) 
Prostate-specific antigen (PSA) is a cancer biomarker for prostate cancer, which is produced by the prostate 
gland and circulate in the bloodstream. Two forms of PSA proteins exist in the blood and seminal fluid: bound 
and free PSA. The level of total PSA can be used for prostate cancer indication. The small amount of PSA in 
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serum is found in healthy men, but it is elevated in the men who may have a risk of prostate cancer. The value 
of PSA level is shown as follows; normal PSA = 0-4 ng/mL, slightly elevated PSA = 4-10 ng/mL, moderately 
elevated PSA = 10-20 ng/mL, highly elevated PSA = 20+ ng/mL. However, the elevated PSA level will also 
cause by uncontrollable factors, e.g. age, family history, and race, which is called noncancerous prostate 
enlargement. There are two ways to forecast the state of cancer; (i) the detection of free PSA, and (ii) evaluation 
of ratio between free PSA and total PSA. For first evaluation, the reduction of PSA level has been focused. It 
results from the PSA that releases from the cancerous cell is bound PSA, not free PSA. Therefore, the free 
PSA level from patients is low by comparing with those from normal men. In the case of another PSA 
evaluation, the ratio of free PSA: total PSA is an additional test for PSA diagnosis. The ratios between free/total 
PSA are different in men with a different state of cancer. The lower ratio of free/total PSA is found from 
patients. Whereas, higher free/total PSA is detected from normal men. Regarding the clinical report, the 
decrease of PSA level showed the high risk for prostate cancer. Therefore, to improve the detection limit to 
detect trace amount of PSA (cancer biomarker) is the big challenge for monitoring and observing the patient’s 
condition. The detection result is very important for cancer screening and implements medicine treatment.  
 
5.2 Experimental  
5.2.1 SERS probe synthesis 
SERS probes of different sizes were prepared in the following three steps: (i) synthesis of citrate-capped 
AuNPs of different sizes, (ii) labeling and stabilizing the AuNPs with MBA and PEG molecules, respectively, 
and (iii) antibody immobilization. The details of the citrate-capped AuNP synthesis are already described in 
the previous section. After the concentration of the obtained aqueous solution of citrate-capped AuNPs was 
adjusted so that the optical density became unity (optical path length = 10 mm) at the peak wavelength of 
LSPR, the AuNPs were labeled with MBA by adding a 1mM solution of MBA in ethanol to the stirred solution 
of citrate-capped AuNPs (1 mL). The stirring was continued for 3 h at RT. The amount of MBA solution used 
in this treatment was varied depending on the size of AuNPs (See Table 5-2). Then, to stabilize the particles, 
100 µL of a 1 mM aqueous solution of SH-PEG-COOH was added to the stirred colloidal solution, and the 
stirring was continued for 1 h at RT. The excess amount of MBA and SH-PEG-COOH were removed by two 
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cycles of centrifugation and re-dispersion in DI water. The rotation speed of centrifugation was varied 
depending on the size of AuNPs (see Table 5-2). After this washing treatment, the optical density of the 
colloidal solution of PEGylated MBA-labeled AuNPs was brought back to unity by adding a proper amount 
of DI water. 
Finally, antibody immobilization was performed as follows.  Since MBA and SH-PEG-COOH bind 
to the AuNP surface by forming Au-S bonds, the carboxyl groups are exposed outward.  The solvent of 1 mL 
of the aqueous solution of PEGylated MBA-labelled AuNPs was exchanged with the same volume of PBS 
solution. The carboxyl groups of MBA and SH-PEG-COOH binding to AuNPs were activated by adding a 
mixture of 100 µL of 15 mM EDC in PBS solution and 100 µL of 15 mM NHS in PBS solution to the colloidal 
solution and stirring the mixture for 30 min. After the excess amount of EDC and NHS were removed by three 
cycles of centrifugation and re-dispersion in PBS solution, antibodies were immobilized on the PEGylated 
MBA-labeled AuNPs by adding an antibody solution (10 µL of a 1 mg/mL solution of anti H-IgG or 10 µL of 
a 1 µg/mL solution of PSA monoclonal detection antibody in PBS solution) to 1 mL of the colloidal solution. 
This solution was kept at 4 C overnight to complete the immobilization. The unreacted antibodies were 
removed by two cycles of centrifugation and re-dispersion in PBS solution, and then the remained colloidal 
solution was re-dispersed in 1% (w/v) BSA in PBS solution for blocking the nonspecific binding site. The 
unreacted BSA was removed by two cycles of centrifugation and re-dispersion in PBS solution. In the last re-
dispersion process, the concentrated suspension was re-suspended in PBS solution so that the final volume 
became 1 mL. This suspension was stored at 4C until use. The particles were dispersed by sonication before 
use. Hereafter, the PEGylated MBA-labeled immunogold is referred to as SERS probe, and for simplicity the 
size of SERS probe is specified by the Au core diameter. 
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Table 5-2 Amount of 1 mM ethanolic solution of MBA used for labeling AuNPs of different sizes and 
centrifuge rotor speed for AuNPs of different sizes. 
Diameter of AuNPs 
(nm) 
Amount of MBA solution 
(µL) 
Centrifuge rotor speed 
(rpm)  
26 300 10,000 
31 300 10,000 
42 300 8,000 
53 200 7,000 
77 300 5,000 
110 400 5,000 
 
5.2.2 Sandwich immunoassay protocol 
The sandwich immunoassays for H-IgG and PSA were performed on the SERS substrates (2D arrays of Au 
(42 nm-core)@Ag (5 nm-shell) NPs) and Au evaporated film substrates (reference substrates). The preparation 
process of both substrates was already mentioned in the previous chapter. [104] In the last preparation step, 
these substrates were hydrophilized by surface modification with MHDA. Just before immunoassay, these 
substrates were immersed in a mixed aqueous solution of EDC and NHS (15 mM each) for 1 h in a dark 
chamber in order to activate the carboxyl group of MHDA. The unreacted reagents were removed by rinsing 
with PBS solution 3 times. 
In the immunoassay for H-IgG, 10 µL of a PBS solution containing anti H-IgG at a concentration of 
1 mg/mL was dropped onto the substrates (5  5 mm2) and incubated overnight in a moist chamber at 4C for 
immobilizing the capture-antibody. To remove the unreacted antibodies, the substrates were washed with a 
PBS solution containing the detergent Tween 20 at a concentration of 0.05% (TPBS) and then rinsed with PBS 
solution. The non-specific binding sites were blocked with BSA, which was conducted by immersing the 
substrates in a PBS solution with 0.05% (w/v) BSA for 30 min. The free BSAs were removed by sequential 
rinsing with TPBS and PBS solution. The immunosubstrates were stored in a PBS solution at 4C until use. 
Then, the antigen immobilization was performed by dropping 10 µL of a PBS solution containing H-IgG 
antigen onto the immunosubstrates and keeping them in a moist chamber at 4C for 20 min. The unbound 
antigen was removed by sequential rinsing with TPBS and PBS solution. Next, 10 µL of an aqueous solution 
of the SERS probes was pipetted onto the immunosubstrates, and the solution was kept on the substrates for 
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10 min to complete the antigen-antibody binding. To remove unreacted SERS probes, the substrates were 
rinsed sequentially with TPBS, PBS solution, and DI water and dried under N2 gas flow.  Finally, the Raman 
spectra of the substrates were measured. 
 The protocol of immunoassay for PSA was the same as that for H-IgG, except for the following 
conditions; the concentration of the PSA capture-antibody in PBS solution was 1 µg/mL, and the capture-
antibody was incubated at room temperature (RT) for 6 h; the incubation for immobilizing the PSA antigen 
was performed at RT for 3 h; and the SERS probe immobilization was carried out at RT for 3 h. The protocols 
of the sandwich SERS immunoassays for H-IgG and PSA are illustrated in Fig. 5-1. The immunoassay 
conditions for the two systems were determined based on those reported in literatures [105-107]. 
  
5.3 Results and discussion 
5.3.1 Characterization of SERS probe 
First, we examined the size distribution and shape uniformity of the Au core particles.  The SEM images of 
citrate-capped AuNPs of different sizes are shown in Fig. 5-2(a), indicating that the shape is nearly sphere for 
all the sizes. The size distribution (average ± standard deviation) evaluated from one hundred particles in the 
SEM images taken with a magnification of 100k was: 26 ± 2 nm, 31 ± 2 nm, 42 ± 4 nm, 53 ± 5 nm, 77 ± 8 nm, 
and 110 ± 8 nm.  The relative standard deviation was approximately less than 10 % for all the sizes.  The 
uniformity of AuNPs is crucial for examining the probe size dependence of the sensitivity of immunoassay.  
Figure 5-2(b) shows the extinction spectra of the PBS solutions of SERS probes of different sizes. The 
 
Fig. 5-1 Schematic illustration of sandwich immunoassays for Human IgG and PSA.  
61 
 
maximum of the extinction band assigned to the LSPR was located at 529, 534, 543, 553, 575, and 607 nm for 
the 26, 31, 42, 53, 77 nm and 110 nm-SERS probes, respectively, and the bandwidth increased with increasing 
particle size.  Similar spectral change of the LSPR band with increasing particle size was commonly observed 
for aqueous colloidal solutions of AuNPs [108-110]. The spectral change is attributed to the electromagnetic 
retardation effects in larger particles, which increases the contribution of higher-order plasmon modes to the 
extinction spectra for larger particles [111]. The LSPR of the SERS probes was slightly red-shifted (2-3 nm) 
compared to that of the citrate-capped AuNPs of the same size, which was induced by capping AuNPs with 
MBA, PEG, and antibody (data not shown). 
Figure 5-2(c) shows the Raman spectrum of the 53 nm-SERS probes drop-casted on a Si substrate, 
together with that of solid MBA. The very strong Raman bands assigned to the 12 and 8a aromatic ring 
vibrations [112,113] were observed at 1089 and 1587 cm-1 for the SERS probes. These peak positions were 
slightly lower than those of solid MBA (1112 and 1607 cm-1, respectively). From these peak shifts, we 
confirmed that MBA was chemisorbed on AuNPs [112]. In this study, the 1587 cm-1 band was used for 
detection of target analytes, because the 1587 cm-1 band was well-separated from the Raman signal arising 
from the SERS substrates (2D-arrays of Au@Ag NPs) typically displayed at 1003, 1035, 1110, 1143, 1180, 
1340, 1454, and 1530 cm-1.  
The successful immobilization of antibody on the PEGylated MBA-labeled AuNPs was confirmed by 
measuring the FTIR spectra in an ATR geometry. Figure 5-2(d) shows the IR spectra of the PEGylated MBA-
labeled AuNPs and SERS probes drop-casted on Si substrates. In the spectrum of PEGylated MBA-labeled 
AuNPs, the IR bands assigned to the C=O stretching of COOH group and the C-S vibration [114] were 
observed at 1691 and 1111 cm-1, respectively. The observation of these bands indicates the existence of MBA 
and/or SH-PEG-COOH molecules chemisorbed on AuNPs. After antibody immobilization, the 1691 cm-1 band 
disappeared and the bands assigned to the C=O of the amide bond and the N-H stretching of antibody [115] 
appeared at 1656 and 3243 cm-1, respectively.  From these spectral changes, the antibody was confirmed to be 
immobilized on the SERS probes via the amide linkage.  
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5.3.2 Influence of SERS probe size on the sensitivity of SERS immunoassay 
To roughly examine the influence of the SERS probe size on the sensitivity of immunoassay, the sandwich 
immunoassay for H-IgG was performed on the SERS substrates using SERS probes of different sizes (26, 31, 
42, 53, 77, and 110 nm in diameter) at a constant target analyte concentration of 1 ng/mL. Figure 5-3(a) shows 
the SERS spectra of the sandwich immunoassay. The intensity of the characteristic bands of MBA increased 
with increasing probe size until 53 nm and then decreased. The probe size dependence of the 1587 cm-1 band 
intensity is shown in Fig. 5-3(b), which clearly shows that it becomes maximum at a probe size of 53 nm. This 
result suggests that the size of the SERS probes that provide the highest sensitivity enhancement lies about 50 
nm. 
 
Fig. 5-2 (a) SEM images of the citrate-capped AuNPs of different sizes. (b) Normalized extinction spectra 
of the PBS solutions of SERS probes of different sizes. (c) Raman spectra of the solid MBA and the 53 
nm-SERS probes. (d) ATR-FTIR spectra of the PEGylated MBA-labeled AuNPs and the SERS probes of 
53 nm in diameter.  
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The sensitivity of SERS immunoassay must be discussed based on the slope of the sensitivity curve, 
which is the relationship between the SERS intensity and the concentration of target analyte. Thus, we 
determined the sensitivity curves of the sandwich immunoassay for SERS probe sizes of 26, 53, and 110 nm, 
which were selected as representative small, middle, and large probe sizes. The concentration of H-IgG antigen 
was varied from 0.1 pg/mL to 10 ng/mL by serial dilutions of H-IgG antigen solution. Figure 5-4 shows the 
sensitivity curves obtained by plotting the 1587 cm-1 band intensity as a function of the logarithm of H-IgG 
concentration. The corresponding SERS spectra are shown in Fig 5-5. As shown in Fig. 5-4, the linear 
relationship was obtained in the H-IgG concentration range of 0.1 pg/mL to 10 ng/mL for all SERS probe sizes. 
The linear sensitivity curves obtained by the method of least squares are: y = 306 x + 4110 (r2 = 0.97) for 26 
nm-probes, y = 726 x + 9951 (r2 = 0.98) for 53 nm-probes, and y = 377 x + 5268 (r2 = 0.86) for 110 nm-probe.  
By comparing their slopes, the sensitivity of immunoassay using 53 nm-probes was found to be approximately 
2-fold higher than those using 26 nm- and 110 nm-probes. This probe size dependence of the immunoassay 
sensitivity is in good agreement with that of the SERS intensity at a constant H-IgG concentration shown in 
Fig. 5-3b. From these results, we conclude that the optimal SERS probe size is 53 nm.  Here, we should note 
that the optimal size of SERS probes depends on the structure of SERS-active substrates used for immunoassay.  
 
 
Fig. 5-3 (a) SERS spectra of the sandwich immunoassay for H-IgG performed at a constant H-IgG 
concentration of 1 ng/mL using SERS probes of different sizes. (b) Probe size dependence of the SERS 
intensity of the 1587 cm-1 band. The broken curve is a guide for the eye. 
64 
 
 
We would like to discuss briefly why the maximum sensitivity is observed at a SERS probe size of 53 
nm. Figure 5-6a shows the representative SEM images of the immunoassay substrates performed at a constant 
H-IgG concentration of 1 ng/mL using SERS probes of different sizes. (The corresponding SERS data are 
shown in Fig. 5-3).  One can distinguish between the SERS probes and the Au@Ag NPs of the SERS substrate 
by the difference in size and brightness. The SERS probes situated at the top layer of 2D array appear brighter 
in the SEM images than the Au@Ag NPs. By counting SERS probes in the SEM images (3.5 × 2.5 m2) 
taken at five different positions, their surface density was evaluated.  The result is shown in Fig. 5-6(b). The 
immobilized probe density decreased with increasing probe size, indicating that the immobilization probability 
of SERS probes decreased with increasing probe size. This may be due to the insufficient binding strength of 
antigen-antibody for immobilizing large SERS probes. 
From the observed SERS intensity (Iob), the probe density (dp), and the excitation laser spot diameter 
(wL = 4 m), the SERS intensity per a single SERS probe (Is) can be calculated by Is = 4Iob/(wL2dp ). Is is 
proportional to the effective Raman cross-section of a single SERS probe. The calculated results are shown in 
Fig. 5-6(c), indicating that the effective Raman cross-section increases with increasing probe size. This probe 
size dependence can be understood by considering the following two effects: one is the increase of Raman 
reporter molecules with increasing probe surface area, and the other is the decrease of the electromagnetic 
 
Fig. 5-4 Sensitivity curves of H-IgG immunoassay using three probe size (26, 53, and 110 nm). The 
broken straight lines were obtained by the method of least squares. 
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field enhancement effect with increasing probe size due to the electromagnetic retardation effect. In the probe 
size range of less than 110 nm, the former effect is dominant. In consequence of the balance between the 
increase of Is and the decrease of dp with increasing probe size, the sensitivity enhancement showed a maximum 
around a probe size of 50 nm. 
 
 
 
Fig. 5-5 Raman spectra of immunoassay for H-IgG performed on the SERS substrates using (a) 26, (b) 
53, and (c) 110 nm-SERS probes. The concentration of the antigen solution was varied from 0 (control) 
to 10 ng/mL: a = control, b = 0.1 pg/mL, c = 1 pg/mL, d= 10 pg/mL, e = 0.1 ng/mL, f = 1 ng/mL, and g = 
10 ng/mL. 
 
66 
 
 
5.3.3 Influence of separation distance between SERS probe and substrate on the sensitivity of SERS 
immunoassay 
The influence of the size of sandwich immunocomplexes on the sensitivity of SERS immunoassay was 
examined. PSA and H-IgG were selected as representative small and large sandwich immunocomplexes 
[116,117], respectively, and 53 nm-SERS probes (optimized probe size) were used in these immunoassays. 
The molecular weights of the H-IgG antibody and antigen, and the PSA antibody (IgG2a isotype) were 
approximately 150 kDa, whose molecular size was reported to be 15  10  4 nm3 [118].  The molecular weight 
of the PSA antigen was 30 kDa, and its molecular size was estimated to be 4 nm in diameter by assuming the 
shape of PSA antigen as a globular shape [119], which was in good agreement with the molecular dimension 
estimated by simulation [117]. Thus, the size difference between the H-IgG and PSA sandwich 
immunocomplexes mainly arises from the difference in size of antigen. It is very difficult to determine the size 
of sandwich immunocomplex that determines the separation distance between the SERS substrate and SERS 
probe because it depends on the alignment structure of the capture antibody, antigen, and detection antibody. 
For simplicity, in this study the size of sandwich immunocomplex was estimated by sum of each component 
 
Fig. 5-6 (a) Representative SEM images of sandwich immunoassay substrates performed at a H-IgG 
concentration of 1ng/mL using SERS probes of different sizes. Probe size dependence of (b) probe density 
and (c) SERS intensity of a single probe. The broken curves are guides for the eye. 
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size. Here, the sizes of the H-IgG antibody and antigen and the PSA antibody were assumed to be 12 nm [116], 
and the size of the PSA antigen was 4 nm. 
The sensitivity curves for the detection of different analytes cannot be compared directly, because the 
ability of different antibodies to be immobilized onto the surface and the affinity towards their target antigens 
are different. Thus, the sensitivity enhancement factors obtained by replacing an Au film with the SERS 
substrate were evaluated for H-IgG and PSA detection, and then compared. By doing this, the influence of the 
size of sandwich immunocomplex on the sensitivity of SERS immunoassay could be investigated. To obtain 
the sensitivity curves of SERS immunoassay for H-IgG, the concentration of H-IgG antigen solution was 
varied from 0.1 pg/mL to 10 ng/mL. For the control sample, the PBS solution without H-IgG antigen was 
dropped onto the substrates. Figures 5-7(a) and 5-7(b) show the Raman spectra of the immunoassay for H-IgG 
conducted on the SERS and Au film substrates, respectively. The sensitivity curves obtained by plotting the 
peak intensity of the 1587 cm-1 band as a function of the concentration of H-IgG are shown in Fig. 5-8(a). The 
linear relationship was observed in the concentration range of 0.1 pg/mL to 10 ng/mL for both Au film and 
SERS substrates. The linear relationships determined by the method of least squares are: y = 726 x + 9951 (r2 
= 0.98) for the SERS substrate and y = 310x + 4335 (r2 = 0.87) for the Au film substrate.  By comparing the 
slopes, the sensitivity was found to be enhanced 2.3-fold by replacing the Au film substrate with the SERS 
substrate. 
The sensitivity curves of the immunoassay for PSA are shown in Fig. 5-8(b), where the concentration 
of PSA solution was varied from 0.01 pg/mL to 1 ng/mL. The Raman spectra of the immunoassay for PSA on 
the SERS and Au film substrates are shown in Fig. 5-7(c) and 5-7(d), respectively. Figure 5-8(b) shows the 
sensitivity curves of the immunoassays for PSA performed on both substrates. The linear relation was found 
in the range of 1 pg/mL to 1 ng/mL: y = 827 x + 10461 (r2 = 0.95) for the SERS substrate and y = 128 x + 1742 
(r2 = 0.90) for the Au film substrate. By comparing the slopes, the sensitivity of the immunoassay conducted 
on the SERS substrate was found to be 6.4-fold higher than that of the Au film substrate.  
By comparing the sensitivity enhancement factors, we found that the sensitivity of the sandwich-type 
SERS immunoassay increased by a factor of 3 as the size of the sandwich immunocomplex decreased from 36 
nm to 28 nm. This result can be understood by the increase of the plasmon coupling between the SERS probe 
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and the SERS substrate with decreasing separation distance between them, suggesting that the sensitivity of 
SERS-based immunoassay performed on SERS-active substrates can be improved by adopting an antibody-
fragment instead of the antibody. Here, we note that the reduction of the affinity to bind with the target antigen 
must be avoided in producing antibody-fragments.  
The SERS-based immunoassay reported here showed low LODs of 0.3 pg/mL (10 fM) for PSA and 
0.05 pg/mL (0.3 fM) for H-IgG. The estimated LOD of our system for PSA was lower than those of the 
previously reported SERS immunoassays: 1 pg/mL for Au substrate with 5,5'-dithiobis(succinimidyl-2-
nitrobenzoate)-labelled 30 nm-AuNPs probes [106] and, 1 pg/mL for 2D array of 20 nm AuNPs with 
rhodamine 6G-labelled 20 nm-AuNPs probes [120].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5-7 Raman spectra of the immunoassay for H-IgG performed on (a) SERS (2D array of Au@Ag 
NPs) substrates and (b) Au film substrates using 53 nm-SERS probes.  The concentration of antigen 
solutions are: a = 0 (control), b = 0.1 pg/mL, c = 1 pg/mL, d= 10 pg/mL, e = 0.1 ng/mL, f = 1 ng/mL, and 
g = 10 ng/mL. Raman spectra of the immunoassay for PSA on (c) SERS and (d) Au film substrates using 
53-nmSERS probes. The concentration of antigen solutions are: a = 0 (control), b = 0.01 pg/mL, c = 0.1 
pg/mL, d= 1 pg/mL, e = 0.01 ng/mL, f = 0.1 ng/mL, and g = 1 ng/mL. 
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5.4 Conclusion  
The Influence of the sizes of SERS probe and sandwich immunocomplex on the sensitivity of sandwich-type 
SERS immunoassay has been investigated. Antibody-conjugated MBA-labeled AuNPs were served as the 
SERS probes. To enhance the SERS signal generated from the probe, the immunoassay was performed on the 
2D arrays of Au@Ag NPs (SERS-active substrates). The sensitivity of immunoassay for H-IgG detection 
increased with increasing probe size up to 53 nm, and beyond this probe size, it began to decrease. We found 
that the sensitivity could be improved by a factor of 2 by using 53-nm probes, instead of 26 nm- or 110 nm-
probes. Next, the influence of the size of sandwich immunocomplex on the sensitivity was examined by 
performing the sandwich immunoassay for H-IgG and PSA detection with 53 nm-SERS probes. We found that 
the sensitivity of the immunoassay increased by a factor of 3 as the size of sandwich immunocomplex 
decreased from 36 nm to 28 nm. This sensitivity enhancement can be attributed to the stronger plasmon 
coupling at the shorter separation distance between the SERS probe and the SERS substrate. This finding 
suggests that the sensitivity of sandwich SERS immunoassay performed on SERS-active substrates can be 
 
Fig. 5-8 Sensitivity curves of the sandwich SERS immunoassays for (a) H-IgG and (b) PSA performed on 
the SERS and Au film substrates. The broken lines are obtained by the method of least squares. Schematic 
illustration of sandwich immunoassay for (c) H-IgG and (d) PSA.  
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improved by replacing the capture- and detection-antibodies with antibody-fragments if the affinity of the 
antibody-fragments to bind with the target antigen is unchanged. 
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CHAPTER VI 
SUMMARY 
 
In this dissertation, we have developed the highly sensitive immunoassay based on the SERS readout. 
This goal has been achieved by designing the suitable model of SERS substrate for immunoassay, structure 
and chemical constituents of SERS probe, and format of SERS immunosensors. Our SERS immunosensors 
consisted of two main components: SERS-active substrate and SERS probe. In the first step, the appropriate 
SERS substrates for immunoassay were developed. Before immunoassay, the SERS substrate (Au@Ag core-
shell NPs 2D array), which has been proved to be highly sensitive SERS-active substrate [70], was fabricated 
by using the hybrid method. The as-prepared 2D array is hydrophobic substrate because the capping molecules 
are the mixture between dodecanethiol and octadecanethiol. The surface modification of this substrate is 
important for utilizing it as a solid support in an immunoassay because the hydrophobic substrate is not suitable 
for immunoassay. The hydrophilization was successfully performed by replacing hydrophobic molecules of 
mixed alkanethiols with a hydrophilic molecule of MHDA. At this step, this MHDA functionalized-SERS 
substrate is now suitable for utilizing as a solid support in SERS immunoassay because (i) biomolecules are 
able to bind to this substrate via amide bond formation between COOH of MHDA and NH2 of biomolecules, 
and (ii) its LSPR (627 nm) matches to the excitation wavelength (632.8 nm) of our Raman system. Then, the 
SERS probes were fabricated by selecting 25-nm Au sphere as supporting material, TBBT as Raman reporter 
molecule, the mixture of PEG-SH and COOH-PEG-SH as protecting shell. The usability of the combination 
between the hydrophilized Au@Ag core-shell 2D array (SERS substrate) and TBBT-PEGylated-25 nm AuNPs 
(SERS probe) was demonstrated as a SERS immunosensor for influenza A detection employing direct 
immunoassay format. The nucleoprotein of influenza A was used as a target antigen. The specific recognition 
of antigen-antibody complexes was detected by measuring the SERS signal of TBBT molecule, which is the 
labeling molecule of SERS probe. To improve the sensitivity, the immunoassay was performed on the 2D 
arrays of Au@Ag core-shell NPs (SERS substrate). The sensitivity of immunoassay was enhanced 4 times 
by using SERS substrate instead of flat Au substrate. It indicates that sensitivity improvement is attributed to 
the plasmon coupling between SERS substrate-probe. This SERS immunoassay for influenza A shows high 
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specificity to nucleoprotein against other proteins and high reproducibility with acceptable %RSD value. 
Moreover, this SERS immunosensor was applicable for detection of target nucleoprotein in the complex 
matrices (infected allantoic fluid) with a low limit of detection about 6 TCID50/mL. From the viewpoint of the 
plasmon coupling, the direct-type immunoassay is preferable, because of no need of capture-antibody: i.e. 
shorter separation distance. However, this immunoassay format suffers from lack of specific binding of antigen 
to the immunoassay substrate. The co-adsorption of the target antigens and other components of no interest 
generally occurs, leading to the lowering of the sensitivity. This disadvantage can be improved by using 
sandwich immunoassay format, which contained the layer of capture antibody on the substrate for selective 
binding with target analytes and decreasing non-specific adsorption of other protein. The sandwich 
immunoassay is expected to be highly sensitive, specific and reliable. However, the separation distance 
between the SERS probe and the SERS-active substrate should increase by the presence of capture-antibody, 
weakening their plasmon coupling. Therefore, the optimization of the SERS probe size and the minimization 
of the separation distance are essential for realizing a highly sensitive sandwich-type SERS immunoassay. 
Then, the sandwich-type SERS-based immunoassay has been developed using hydrophilized 2D 
arrays of Au@Ag NPs as the SERS-active substrates. We have investigated the influence of the sizes of SERS 
probe and sandwich immunocomplex on the sensitivity. The SERS probes are AuNPs functionalized 
sequentially with MBA, HS-PEG-COOH, and the antibody specific to a target antigen. MBA was selected as 
the Raman reporter molecule because it shows strong Raman bands at 1099 and 1596 cm-1 and has a carboxyl 
group for antibody immobilization. To realize highly sensitive detection, the optimization of SERS probe for 
sandwich immunoassay for H-IgG was carried out by varying the Au-core size of SERS probe from 26 to 110 
nm. The maximum SERS intensity/sensitivity was found by using 53-nm-Au-core SERS probe. Next, to 
examine the influence of the size of sandwich immunocomplex on the sensitivity, the sandwich immunoassays 
for H-IgG and prostate-specific antigen (PSA) detection were performed using the SERS probes with 53 nm 
Au core size. The sandwich immunoassays for H-IgG and PSA were chosen as the large (36 nm in total size) 
and small (28 nm in total size) immunocomplexes, respectively. The sensitivity improvement of immunoassay 
performed on SER substrate was realized compared with that conducted on flat Au substrate. The large 
sensitivity improvement was obtained from the PSA immunoassay. It indicates that the short antigen/antibody 
length induces the strong plasmon coupling between SERS substrate-probe. By comparing the sensitivity 
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enhancement factors, we found that the sensitivity of the sandwich SERS immunoassay increased by the 
decrease of antigen size: i.e. the decrease of sandwich immunocomplex size. This result suggests that the 
sensitivity of SERS-based immunoassay performed on SERS-active substrates can be improved by reducing 
the size of sandwich immunocomplex, which can be achieved by replacing the antibody with an antibody-
fragment with the same affinity to the target antigen.  
Finally, we have succeeded in improving the performance of SERS immunoassay by using a 
hydrophilized 2D array of Au@Ag core-shell nanoparticles as a SERS substrate. We have demonstrated that 
the combined use of SERS substrate and Raman reporter molecule labeled-AuNPs decorated with the antibody 
(SERS probe) shows highly sensitive detection. The enhancement is attributed to the plasmon coupling 
between probe and substrate. The utilization of SERS-active substrate as a solid support for improving 
sensitivity has been previously reported by many groups. There are various designs and structures of the SERS-
active substrates using in the immunosensors. However, the consideration of the uniformity of the substrate 
was very high, but the matching of LSPR of the substrate with excitation laser wavelength is still lacking. 
Therefore, we concerned the matching of LSPR of SERS-active substrate with laser line of 632.8 nm in Raman 
measurement to maximize the enhanced electromagnetic field. LSPR can be tuned by designing the structure 
of Au@Ag core-shell NPs. These sensitivity improvements also involved the optimization of SERS probe, 
type of immunoassay, and the size of the biomolecules. The sensitivity enhancement of SERS immunosensor 
strongly depends on probe size and the separation distance between probe and substrate. These studies are the 
guideline for fabrication of high sensitive sandwich SERS immunosensor. By comparing our immunosensor 
to other available immunosensors today, the high sensitivity is an advantage of our SERS immunosensor. In 
the aspect of practical application, however, our SERS immunosensor is still far from other methods that used 
routinely in the clinical laboratory because of many sample preparation steps and low coverage of biomolecule 
or SERS probe on the substrate. By simplifying preparation steps, increasing the density of SERS probe on 
the immunosubstrate, and decreasing of detection time, this sensor may be able to use as an alternative practical 
sensor without the requirement of the specialized personnel.  
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Future perspective  
In this study, we optimized many parameters for sensitivity improvement in SERS immunoassay. Our work 
shows that SERS offers high enhancement with appropriate SERS substrate, SERS probe size as well as the 
molecular size of antigen/antibody. These findings are the guidance for further improvement of SERS 
immunosensor. Progress in SERS immunosensor has been vastly focused on the development of the sensitivity 
of the sensor. However, there are some important points should be concerned to employ SERS immunosensor 
as the practical application, such as the production of SERS substrate with inexpensive, easy to handle, large 
enhancement, uniform, and reliable. Moreover, the regeneration of the SERS substrate or recyclable SERS 
substrate with maintaining the SERS activity after detection method is also necessary. Therefore, the 
regeneration step should be carried out. The substrate may possibly regenerate by using glycine-HCl buffer 
solution, which is mostly used to regenerate the metal surface. This idea will pave the way to further extend 
the improvement of SERS immunosensor.  
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APPENDIX 
 
Surface potential change of cationic nanoparticles by polymer coating  
1. Introduction  
Recently, various types of nanostructures containing structured surfaces and particles have been widely 
developed. Semiconducting/metallic nanoparticles, in particular, are promising candidates as new functional 
materials not only as catalysts but also as durable materials for use in novel optical sensors [121] and other 
devices [122]. Methods for their production have also been widely developed. These methods are usually 
classified into two types: “top-down” methods and “bottom-up” methods. The author’s group have been 
investigating the bottom-up methods primarily [70,73]. Among many types of metallic nanoshapes are used 
in many kinds of chemical sensors [123]. In these cases, a common detergent 
cetyltrimethylammoniumbromide (CTAB) is often used as a stabilizer for AuNPs with shapes such as cubes, 
cuboctahedra, octahedral, and rods [124-128]. Among these AuNPs, gold nanorod (AuNRs) are the most 
frequently used AuNPs. The presence of CTAB is important for nanoparticles synthesis; however, it is 
cytotoxic in nature [128]. Its strong attachment to the surface of AuNPs has been demonstrated in the literatures 
[129,130] (e.g., an 8-nm-thick rigid layer on AuNPs has been reported by Wang et al. [130]). Some research 
groups have reported their attempts to modify CTAB coating to other polymeric surfactant coatings 
[129,131,132]. These group focused on AuNRs because of their potential biological applications. In some 
cases, isotropic AuNPs exhibit a high positive charge density caused by CTAB cations. Highly surface-charged 
particles are strongly affected by a change in ionic strength. For some biological applications, we would prefer 
to avoid volatile organic contaminants and handle AuNPs only in the aqueous phase. In this paper, we describe 
a simple surface modification of CTAB(1)-coated AuNPs (referred to as CTAB(1)-AuNPs, hereafter) with 
two polymers used are poly(sodium 4-styrenesulfonate) (PSS(2)) and polyethyleneglycol bisphenol A 
epichlorodrin copolymer (PEG(3)). In order to avoid sample loss, we tried the method omitting the often-used 
biochemical process “dialysis”[133]. We have focused on these two polymers because of their properties of 
decreasing charge density/repulsion for stabilizing particles and the softness of the polymer chain coating, 
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which contrasts with the rigid CTAB(1) [130]. For comparison, we also used sodium dodecyl sulfate (SDS(4)) 
as a low molecular weight, negatively charged ionic coating agent. 
2. Experimental  
All chemicals, such as CTAB(1) (Sigma), PSS(2) (Mw = 70,000; Aldrich), PEG(3) (Mw = 15-29 kDa; Sigma-
Aldrich), SDS(4) (Sigma-Aldrich), gold(III) chloride trihydrate (HAuCl4 3H2O) (Aldrich), ascorbic acid 
(Aldrich),and sodium borohydride (NaBH4) (Wako) were used as received. Water was filtered and deionized 
with a Milli-Q system (resistance 18.2 M, Millipore). 
 AuNPs were synthesized via a common seed-mediated growth method [127]. HAuCl4 3H2O was 
dissolved in aqueous solution of CTAB(1) and reduce with ice-cooled sodium borohydride to form a “seed 
solution”. After 1 h “growth solution” was prepared with additional HAuCl4 3H2O and diluted seed solution. 
This mixture was reduced by addition of ascorbic acid in aqueous CTAB(1) solution. The obtained CTAB(1)-
AuNPs were subsequently mixed with an aqueous solution of another coating agent (2-4). Each mixed solution 
was stirred for 1 h, centrifuged (6.8 krcf, 10 min), and then washed twice with H2O. we hereafter refer to 
CTAB(1)-AuNPs treated with coating agents (2-4) as coating agent (2-4)-AuNPs. UV-Vis-NIR spectra of 
AuNPs were measured using a Jasco V-670 spectrophotometer. The zeta potential (hereafter abbreviated as 
ZP) was determined with an ELSZ-1000 (Otsuka Electronics). Each hydrodynamic diameter (hereafter 
abbreviated as HD) was measured at 25C by the dynamic light scattering (DLS) method using a DLS-8000 
(Otsuka Electronics). Microscopic images and EDX measurements were recorded with either an HD-2000 
(Hitachi) or a JEM-2100F (JEOL) operating at 200 kV. 
 
3. Results and discussion  
3.1 UV-Vis-NIR spectra of AuNPs  
Each absorption spectrum was recorded and normalized at the max of the AuNPs’band; the results are 
presented in Fig.S1. During the treatment with the coating agents (2-4), a portion of the AuNPs aggregated 
and attached to the walls of the container or was washed off. Therefore, the concentration of AuNPs decreased 
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to some extent. Thus, the baseline of each normalized spectrum appeared to shift upward compared to that of 
CTAB(1)-AuNPs. After the treatment, a blue color gradually appeared on the walls of PEG(3)-AuNPs. 
Nevertheless, the max of the AuNPs’band was approximately the same for each AuNPs solution. In some cases, 
as long-term preservation was observed to be problematic, it needs to be improved.  
 
3.2 Zeta-potential measurements 
The ZP values of coating agents (1-4) and the AuNPs treated with the coating agents were measured. The 
observed ZPs are listed in Table 1. CTAB(1) samples were the only ones that exhibited positive values, slightly 
more than those of AuNPs cubes reported in the literature (+23.2 mV) [124]. This result implies that CTAB(1) 
salt ionization ratios of the surface layer on the AuNPs differ. For PSS(2) samples, the observed value of ZP 
in the presence of AuNPs was -25 mV lower than that observed in the absence of AuNPs. This result suggests 
that PSS(2)-AuNPs were completely negatively charged with high coverage of PSS(2). 
 Although the ZPin the presence of AuNPs was approximate – 40 mV, the ZP of PEG(3) appeared to 
be close to zero. This highly negative potential value probably arises from an excess amount of anions around 
the AuNPs in solution. 
 
Fig. S1. Normalized absorption spectra of AuNPs treated with coating agents (1-4): CTAB(1)-AuNPs 
(solid line), and CTAB(1)-AuNPs treated with PSS(2) (dotted line), PEG(3) (broken line), and SDS(4) 
(dotted-chain line). 
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 Based on the change in the ZP of SDS(4)-AuNPs compared to that of SDS(4), SDS(4) appears to form 
hybrid complexes with CTAB(1) [134] and to attach to NPs by mixing with CTAB(1)-AuNPs.  
Table S1. ZPs (mV) of each coating agent (1-4), CTAB(1)-AuNPs, and coating agent (2-4)-AuNPs 
Samples Coating agent only AuNPs 
CTAB(1) +45.8 +38.5 
PSS(2) -41.6 -68.9 
PEG(3) -9.1 -37.3*** 
SDS(4) -66.8 -26.4 
*Values were recorded as soon as possible because each coating agent showed irreversible adsorption onto the 
electrodes and the polystyrene cell walls during the measurements, especially in the case of CTAB(1).   
**AuNPs corresponds to CTAB(1)-AuNPs or coating agent(2-4)-AuNPs.  
***Particles gradually aggregated on the polypropylene microtube walls during storage. Small amount of 
sediments were observed for other AuNPs 
3.3 DLS measurements 
The DLS results are summarized in Table S2. The average HD of CTAB(1)-AuNPs was 55.6 nm and was very 
similar to that of PSS(2)-AuNPs (53.4 nm). Gole et al [129] reported an increase of 3.4 nm in the diameter 
of CTAB(1)-coated AuNRs after being treated with PSS (under experimental conditions that differ from ours). 
The HDs of PEG(3)-AuNPs in aqueous solution are larger than those of CTAB(1)- and PSS(2)-AuNPs.  
One possible reason for this larger HDs is that the hydrophobic parts (“bisphenol A” moiety in PEG(3)) form 
a hybrid structure with CTAB(1) to stabilize the particles. The source of the high negative charge on the AuNPs 
in PSS(2)-AuNPs and SDS(4)-AuNPs is certainly attributable to the presence of PSS(2) and SDS(4), 
respectively. The reason for the high negative charge of PEG(3)-AuNPs, as reported in table S1, is unclear. 
According to the DLS results, the diameter of PEG(3)-AuNPs was large, which suggests the occurrence of a 
hydrodynamic effect between PEG moiety and water of CTAB(1) molecules in their aqueous solutions. In the 
transmission electron microscopy (TEM) images (shown later in Fig. S2), the observed diameters of the AuNPs 
did not substantially differ.  
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Table S2. HDs (nm) of particles in each surfactant (1-4) and CTAB(1)-AuNPs or coating agent (2-4)-AuNPs. 
Samples Coating agent only AuNPs 
CTAB(1) 241 55.6 
PSS(2) 107 53.4 
PEG(3) 124 108 
SDS(4) 219 194 
 
*Each coating agent sample showed small (d2 nm, corresponding to a monomer/oligomer peak), intermediate 
(100-200 nm, micelles), and large (e800 nm, corresponding to a higher complex peaks). The listed values are 
those of middle-sized peaks because of their supposed nature. Each AuNPs sample also showed small (d10 
nm), intermediate (50-200 nm), and large (e500 nm) peaks. The intermediate peaks values are listed.  
**Values were not stable because of the adsorbate nature of each coating agent. 
3.4 Microscopic observation of AuNPs 
CTAB(1)-AuNPs used in this investigation were rather polydispersed. The typical TEM images that were 
observed are presented in Fig. S2 and S3. We observed primarily hexagons and small AuNRs with aspect 
ratios less than 3. Fig. S2 shows a typical projection view of the hexagonal particle. This image indicates that 
the particles shape would be cuboctahedral/octahedral. As Kim et al [128] described, depending on the stage 
of particle growth, the 100 faces are blocked with CTAB (1) because of their strong ability to bind to 100. 
TEM images of each AuNPs are presented in the Fig. S3. Because carbon deposition occurred rapidly during 
the microscopic observations, images were taken within a short time. In Fig.S3, the diameters of the particles 
appear to be similar, in contrast to their HDs reported in Table S2.  
 PSS(2)-AuNPs were dispersed better than others. The particles in other samples were closely packed. 
In the case of PEG(3)-AuNPs, in particular, NPs tended to form multilayers, even in areas with relatively small 
populations of NPs. Compared to the other samples, SDS(4)-AuNPs tended not only to aggregate but also to 
connect to one another, which may be related to the strong interaction between CTAB(1) cations and SDS(4) 
anions [134]. Average particle diameters of the AuNPs calculated from TEM images are 44.7 ± 3.2 nm, 44.1 
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± 3.1 nm, 43.9 ± 3.3 nm, and 42.3 ± 6.5 nm for CTAB(1)-, PSS(2)-, PEG(3)-, and SDS(4)-AuNPs, respectively. 
Based on these calculated values, the average diameters of the AuNPs determined from TEM did not 
substantially differ. Because we did not use chemicals that induced digestive effects, such effects and other 
surface chemical reactions could be excluded in these cases. 
 Fig. S4 shows the typical overlay images of Br K-line maps and bright-field images for CTAB(1)- and 
PSS(2)-AuNPs (images for PEG(3)- and SDS(4)-AuNPs are not shown because no significant changes from 
the images in Fig.S4 are observed). From the Br K-line maps, a decrease in the amount of Br was not evident, 
probably because of the limited measurement time, the initial Br K-line intensity, and the existence of Au-Br 
bonds. Thus, Br was detected in all cases. The situations in aqueous solutions and those on the carbon-
supported cellulose nitrate membrane on copper TEM grids certainly differ. The source of negative charge on 
PEG(3)-AuNPs in our case was suggested to be Br-, the CTAB(1) counter-anion. 
We also measured and investigated the EDS spectra (data not shown) of each AuNPs. In the case of 
PEG(3)-AuNPs, two different areas were detected. One area contained many AuNPs and the other contained 
only polymer chains. Br L-lines were observed in both areas, indicating that the Br- ions were attached to 
PEG(3) polymer surface.  
The differences between the microscopic images and the DLS/ZP results for the solutions may arise 
from the solvent evaporation process. In solutions, particles are possibly to have charges (either positive or 
negative). However, when samples are in a dried state, i.e., solid state, the charges on the AuNPs are 
compensated by the counter charges of the substrate or other molecules in the solutions. In the case of PEG(3), 
because the polymeric chain is highly hydrophilic, AuNPs are coated not only by the molecules of the coating 
agent, but also by numerous water molecules. Therefore, the HD would grow to be much larger than those of 
CTAB(1)- or PSS(2)-AuNPs. In the solid phase (as is the case of samples prepared for microscopic 
observations), AuNPs are dried by solvent evaporation. 
The conditions around the AuNPs in a solution could be controllable by changing the method that is 
used to wash them. However, the ZP measurements indicated the presence of negative charges, which indicates 
that the number of anions located within the HD of the NPs should be larger than the number of the cations. 
In this study, AuNPs were initially coated with CTAB(1). To maintain the negative ZP of the AuNPs after 
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they have been coated with neutral PEG(3), the NP surface must contain more anions than cations. Br mapping 
is observed to be an ineffective method for tracing CTAB(1) cations ( a counter ion is Br-) because of polymer-
CTAB(1) or polymer-Br- interactions. SDS(4) showed strong interaction with CTAB(1) partly aggregated on 
the TEM grids. Based on these results, we observed some interesting relationships between the polymer and 
particle charges. We expect to improve the mixing and washing procedures in future.  
 
 
 
 
 
 
Fig. S2 A typical TEM image of hexagonal shape CTAB(1)-AuNPs on a copper TEM grid  
 
Fig. S3 TEM images of CTAB(1)-AuNPs and coating agent (2-4)-AuNPs: a) CTAB(1)-AuNPs, b) 
PSS(2)-AuNPs, c) PEG(3)-AuNPs, and d) SDS(4)-AuNPs. Scale bars: 100 nm 
 
Fig. S4 Typical EDX (Br K) mapping images of a) CTAB(1)-AuNPs and b) PSS(2)-AuNPs 
